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Abstract 
According to the World Health Organization, up to 50% of type 2 diabetic patients 
develop neuropathy, which may cause major infections, amputation, and Charcot foot due 
to impaired sensation. Early recognition and care is essential for treatment of Charcot 
foot and prevention of further injury. Due to the complexity of this potentially life-
threatening complication, assessment is challenging, especially when practitioners who 
treat adult diabetic patients may not be familiar with Charcot foot. The purpose of this 
scholarly project was to develop an assessment, screening tool, and algorithm for 
detecting Charcot foot; an additional goal was to develop practice guidelines for 
practitioners to assist in the early recognition, treatment, and referral of adult diabetic 
patients at risk for Charcot foot. Lippitt’s theory of change was used to guide the project. 
An interdisciplinary team of stakeholders was assembled to guide development of the 
tool, algorithm, and practice guidelines. Products were developed in accordance with 
evidence in current peer-reviewed literature and American Diabetes Association 
recommendations for Charcot foot diagnosis, treatment, and referral. Content was 
validated using a scale content validation instrument process to obtain input from experts 
in the care of Charcot foot. An implementation plan was developed to guide introduction 
of the products into practice, and an evaluation plan created to determine the extent to 
which intermediate term outcomes are met using these products. The project may 
contribute to social change by identifying patients at risk for Charcot foot prior to the 
onset of the complication, therefore preventing further injury, deformity, or amputation in 
populations that are often unable to afford quality healthcare. 
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Section 1: Overview of the Evidence-Based Project 
Introduction 
According to the World Health Organization (WHO), approximately 347 million 
people worldwide have type 2 diabetes, and in 2004, it was estimated that 3.4 million 
people died as a result of complications from high fasting blood sugar (WHO, 2013). The 
WHO projects that the 7th leading cause of death in 2030 will be a direct result of 
diabetes (WHO, 2013). Maintaining a healthy diet, a normal body weight, avoiding 
tobacco use, and incorporating regular physical activity can prevent or delay the onset of 
type 2 diabetes. According to National Diabetes Information Clearinghouse (NDIC), 
diabetes is the seventh leading cause of death in the U.S. and affects millions of 
Americans (NDIC, 2011). The virulence of diabetes and its prevalence has steadily 
increased over the years and continues to rise. Fowler (2007) reports that diabetes has 
become a major cause of morbidity and mortality in the United States, which also 
continue to increase globally each year. “The magnitude of current statistics indicates that 
diabetes will continue to affect the United States population for the foreseeable future and 
is by no means limited to the United States” (Fowler, 2007, para. 5). Of the millions of 
Americans who are diagnosed every year, the number of those who go undiagnosed is 
even greater, meaning everyone should observe the warning signs and have routine 
screenings completed. Type 2 diabetes is a devastating chronic disease with the potential 
to have life-long effects to all major organs including kidneys, heart, eyes, and blood 
vessels. The American Diabetes Association (ADA) reports that type 2 diabetes produces 
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severe systemic complications such as nephropathy, neuropathy, retinopathy, foot 
complications, heart disease, stroke and many other devastating health problems, which 
occur due to uncontrolled elevated glycemic levels (ADA 2013). Maintaining controlled 
blood sugar levels can help prevent these complications.  
Problem Statement 
Diabetic neuropathy is the most prevalent complication of type 2 diabetes, 
affecting up to 50% of all diabetic patients (WHO, 2016). Peripheral neuropathy, 
meaning peripheral nerve damage, causes significant issues such as nonhealing wounds, 
major infections, and amputations. Another consequence of peripheral neuropathy can be 
Charcot neuropathic osteoarthropathy (CN), commonly referred to as Charcot foot, which 
involves the soft tissue and bones of the foot and ankle and leads to permanent 
deformities. This condition may ensue if the bones in the feet suffer fractures and the foot 
becomes misaligned. Although experiencing a fracture would be extremely painful to 
most people, this particular condition can be painless to the diabetic patient due to nerve 
damage from diabetes prior to the fracture. The foot may eventually lose muscle support, 
leading to deformity. Diagnosis can sometimes be difficult due to the potential 
mimicking of other conditions such as deep venous thrombosis or cellulitis; therefore, 
diagnosis of a Charcot fracture cannot be made definitively until bone changes occur. The 
problem identified and addressed in the project is inconsistency by healthcare providers 
in the recognition and referral of patients with potential Charcot foot. 
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Purpose Statement 
According to Lin and Lorenzo (2013, para. 2), “in type 1 DM, distal 
polyneuropathy typically becomes symptomatic after many years of chronic prolonged 
hyperglycemia, whereas in type 2, it may be apparent after only a few years of known 
poor glycemic control or even at diagnosis.” Symptoms affect sensory, motor, and 
autonomic systems of the body. When neuropathy progresses to Charcot foot, it becomes 
a serious, potentially limb-threatening complication and during the acute phase, is 
considered to be an inflammatory syndrome. Due to the rarity of this condition, diagnosis 
and treatment pose a critical issue for healthcare practitioners including nurse 
practitioners (Rogers et al, 2011). The purpose of the project was the development of an 
assessment and screening tool for nurse practitioners providing care for type 2 diabetics 
at risk of Charcot foot, and integration of ADA Charcot diagnosis and treatment 
recommendations for nurse practitioners to assist in the early recognition and treatment of 
Charcot foot with the goal of preventing further complications and possible loss of the 
foot or more of the lower extremity. 
Goals and Objectives 
The purpose of this project was to develop an assessment and screening tool and 
incorporate recommendations set forth by the ADA in an effort to assist healthcare 
practitioners in early recognition, diagnosis, and treatment of Charcot foot in the diabetic 
patient with peripheral neuropathy. In doing so, the goal was to improve consistency in 
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the diagnosis and treatment by healthcare providers of patients with or at risk of Charcot 
foot.  
In this section, I outline the process by which an assessment tool was developed 
as well as discuss its implementation and evaluation. No data was collected nor were 
participants involved as the project involved the development of an assessment tool to 
further assist nurse practitioners (NPs) in the early detection, identification, and treatment 
of type 2 diabetic patients at risk of Charcot foot.   
The outcomes that were used to determine goal attainment for the project included 
an evaluation planning step at the end of this DNP Project. The following outcomes were 
initially suggested as possible starting points for evaluation planning: 
Outcome 1: Healthcare providers will identify, assess, and treat patients with 
Charcot foot. 
Outcome 2: Healthcare providers will refer patients with Charcot foot to 
appropriate specialty for follow up care. 
The detection of patient risks by nurses, which is “the ability of nurses to 
accurately identify signals can lead to early interventions so that harm to patients is 
minimized or circumvented” (Despins, Scott-Cawiezell, & Rouder, 2010, p. 465). Nurses 
and nurse practitioners are at the forefront of patient assessment, which is the first 
opportunity for detection and intervention of potentially life-threatening illness and 
injuries. They have a responsibility to patients to be skilled in their assessment abilities 
and intervene when necessary. Charcot foot, although complex and often difficult to 
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diagnose, is a major complication of diabetes that requires immediate treatment after a 
detailed and skilled assessment by competent healthcare professionals.  
Significance of the Project 
The American Diabetes Association has developed guidelines for all healthcare 
practitioners to follow regarding the diagnosis, treatment, and surgical intervention of 
Charcot foot with the goal of rapid identification of signs and symptoms and appropriate 
treatment regimens as a means of preventing further complications. Currently, there are 
no exclusive assessment and screening tools and treatment algorithms specifically for 
NPs that address the patient at risk of Charcot foot. The project tools will meet the 
guidelines set forth by the ADA. 
Implications for Social Change of Practice 
Accurate assessment of the diabetic foot is a complex process requiring skill, 
experience, and knowledge of not only the disease but also signs and symptoms of 
potential complications. The loss of sensation due to peripheral nerve damage makes it 
difficult for patients to help providers diagnose developing problems. They often present 
with vague symptoms or nonhealing wounds and often unaware of the nature of the initial 
injury. This is exacerbated by the unseen nature of problematic internal changes such as 
destruction of bone tissue and cartilage as a result of uncontrolled hyperglycemia. It is 
crucial that diabetic patients are consistently and closely monitored and made aware of 
the potential complications associated with the disease. According to Meyers (2013), by 
decreasing the incidence of amputations and improving quality of life through education 
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and close monitoring, the result will be a decrease in the amount of funds spent long-term 
for care of the patient with diabetes. However, many clinicians lack experience in the 
area of Charcot foot assessment and often consider it as simply “a diabetic foot.”  
 
Figure 1. Why does Charcot deformity happen? (Perez, 2014)  
According to Zgonis (2010), there is a limited amount of scientific literature in 
regard to treatment protocols and guidelines for management of Charcot foot and ankle 
deformities and may be in part due to the vague presentation of each individual case. 
Although many patients present with obvious deformities, there are a higher number of 
those who have few or vague complaints, which adds to the difficulty of accurate 
diagnosis for the practitioner.  
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Definition of Terms 
The principal terms used throughout this project will be: 
Type 2 Diabetes: Type 2 is the most common type of diabetes and is defined as a 
condition in which the body does not properly utilize insulin. This is also referred to as 
insulin resistance. Typically, the pancreas produces an excess of insulin to accommodate 
elevated blood glucose levels; however, over time it is unable to adequately keep up with 
the body’s demand of insulin to maintain normal blood glucose levels (ADA, 
n.d.).Peripheral neuropathy: Peripheral neuropathy refers to the destruction or 
dysfunction of peripheral nerves, which are damaged by uncontrolled elevated blood 
glucose levels, infection, trauma, metabolic disturbances, and exposure to toxins (Mayo 
Clinic, n.d.). Charcot foot: Charcot-Marie-Tooth (Charcot foot or CMT) was first defined 
in 1886 by three physicians, Jean-Martin Charcot, Pierre Marie, and Howard Henry 
Tooth (Charcot-Marie-Tooth Association [CMTA], 2010). It is a serious and potentially 
life-threatening complication of diabetes, which is characterized by various degrees of 
bone, joint, soft tissue, foot and often ankle involvement due to underlying neuropathy, 
trauma, and perturbations of bone metabolism, and it involves inflammation during the 
acute phase (Rogers et al, 2011).  
Podiatric: Podiatric refers to the specialty of a physician who is a doctor of 
podiatric medicine (DPM), also known as a podiatric surgeon or physician who diagnoses 
and treats conditions of the foot, ankle, and related structures of the leg (American 
Podiatric Medical Association [APMA], 2014).  Acute: Acute means a condition 
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characterized by sharpness or severity or having a sudden onset or short course or 
requiring short-term medical care for serious illness or traumatic injury (acute, 2014).  
Inflammatory: Inflammatory refers to the body's response to either invading 
foreign substances (such as viruses or bacteria) or to direct injury of body tissue 
(inflammatory, 2014).  
Deformity: Deformity is defined as the quality or state of being deformed, 
disfigured, or misshapen (deformity, 2014).  
Amputation: Amputation is the accidental or intentional removal of a limb or 
body part (“amputation”, 2014).  
            
Limitations 
A limitation of this project could be the willingness of all stakeholders to 
participate in the change. The effectiveness and success of a program relies heavily on 
the readiness of interested parties to be actively engaged and ready for change. 
Stakeholders can help (or hinder) an evaluation before it is conducted, while it is being 
conducted, and after the results are collected and ready for use. “Stakeholders are much 
more likely to support the evaluation and act on the results and recommendations if they 
are involved in the evaluation process” (George, Daniel, Frankish, Herbert & Bowie, n.d., 
p. 14). The identified stakeholders for this project included health practitioners who are 
completing the diabetic foot assessment.  
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Relevance to Nursing Practice 
Due to the fact that type 2 diabetics are at risk for numerous multisystem 
complications, all healthcare personnel, including nurse practitioners, have a 
responsibility to patients to be knowledgeable and competent in advanced assessment 
skills in hopes of preventing further complications. According to Rogers et al (2011, p. 
2123), “the Charcot foot in diabetes poses many clinical challenges in its diagnosis and 
management. Despite the time that has passed since the first publication on pedal 
osteoarthropathy in 1883, we have much to learn about the pathophysiology, and little 
evidence exists on treatments of this disorder.” Identification of Charcot foot in its early 
stages is crucial to successful treatment. Patients should be referred to a podiatric 
specialist at the first indication or onset of symptoms. Diagnosis may often be 
challenging, mimicking of other major conditions such as cellulitis or deep venous 
thrombosis, since diagnosis of a Charcot fracture is unable to be definitively made until 
bone changes occur. The initial clinical manifestations of Charcot foot are frequently 
mild in nature; however, they can become more pronounced with repetitive trauma. 
Worsening usually occurs slowly with age and rapid progression is rare but warrants a 
prompt re-evaluation. Since undiagnosed Charcot can lead to serious complications 
including infection, deformity, amputations, disability, loss of employment, financial and 
mental strains, and life-long devastating effects, it is crucial for practitioners to be 
knowledgeable and skilled in assessment and treatment methods. 
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Summary 
This chapter described the significance and relevance of a competent and skilled 
foot assessment for all type 2 diabetics suffering from impaired sensory and are at risk for 
the development of Charcot foot. Lack of knowledge may contribute to undiagnosed 
cases of Charcot and therefore place patients at risk of further complications. An 
assessment tool could assist healthcare providers in rapidly identifying the signs and 
symptoms of Charcot and determining the appropriate treatment or referral to a podiatry 
specialist.  
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Section 2: Review of Literature and Theoretical and Conceptual Framework 
Introduction 
The purpose of this project was to develop an assessment and screening tool for 
nurse practitioners to assist in the early recognition, diagnosis, and treatment of Charcot 
foot in type 2 diabetic patients. The goal was to determine appropriate treatment or 
referral to a podiatric specialist for further evaluation and treatment  in order to prevent 
further complications, including loss of limb,. This section will examine literature 
regarding the effects of untreated Charcot foot as well as appropriate treatment methods.  
Literature Search Strategy 
The literature search was electronically conducted and used the following 
databases: CINAHL, Medline, PubMed, EBSCO, and Walden University Library. 
Articles older than 10 years were not considered. The terms used for the search were: 
diabetes, type 2 diabetes, diabetes statistics, neuropathy, peripheral neuropathy, diabetic 
complications, Charcot, Charcot foot, Charcot-Marie-Tooth, podiatry, podiatric, 
orthopedic complications, foot deformities, diabetic assessment forms, foot assessment, 
and peripheral neuropathy assessment. 
Literature Review 
“Charcot neuroarthropathy is an often overlooked complication in diabetic 
patients with peripheral neuropathy. A group of experts reported that 25% of patients 
referred to their facility who had Charcot neuroarthropathy had not received a correct 
diagnosis at the referring institution. The incorrect diagnoses included infection, gout, 
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arthritis, fracture, venous insufficiency, and tumor” (Botek, Anderson & Taylor, 2010, p. 
596). Botek et al. (2010) focused in detail on the devastating effects of misdiagnosed 
Charcot and emphasized the importance of accurate assessment by healthcare providers. 
The authors also discussed a case in which a 53 year-old male presented to the 
emergency department with a 3 day history of redness, pain, and swelling to the foot and 
ankle and was misdiagnosed with cellulitis, admitted to the hospital for a course of 
antibiotics, discharged home with oral antibiotics, seen at his primary healthcare 
providers office 2-3 more times for follow up, then finally referred to an orthopedic 
specialist where he was accurately diagnosed with Charcot foot in the acute phase. By 
this time, there was irreversible extensive damage to the foot. 
According to O’Rourke (2010), from 1999-2008, of patients who underwent 
either a below or above the knee amputation, 60% suffered from diabetic neuropathy and 
had some type of trauma, nonhealing wound, or other complication such as Charcot foot. 
Centered from a thorough review and analysis of the study, the primary issue for patients 
at high risk of ankle and foot problems was the identification and referral to the 
appropriate specialist (O’Rourke, 2010). Healthcare professionals, including nurse 
practitioners, were among those who did not recognize potential issues, which delayed 
care and led to amputations of the 3,445 patients included in the study.  
Symptoms of Charcot foot affect sensory, motor, and autonomic systems of the 
body. When neuropathy progresses to Charcot arthropathy, it becomes a serious, potential 
limb-threatening complication and during the acute phase is considered to be an 
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inflammatory syndrome. Due to the rarity of this condition, diagnosis and treatment pose 
a critical issue for healthcare practitioners including nurse practitioners (Rogers et al, 
2011). Therefore, an assessment and screening tool for nurse practitioners is needed to 
assist in the recognition, diagnosis, and treatment of Charcot foot in order to prevent 
further injury and possible loss of foot or lower extremity.  
Mumoli & Camaiti (2012) discussed a case of Charcot in the Canadian Journal of 
Medicine in which a 59 year-old male with complaints of a plantar ulcer for two months 
presented to his healthcare provider’s office. However, after examination, his healthcare 
provider discovered that his foot was also deformed. The finding was that the patient had 
such severe neuropathy that he felt no pain at all. They go on to state early detection is 
essential and “prevention of disease progression remains the mainstay of treatment, 
including prompt immobilization, absolute non-weight-bearing and professional foot care 
on a regular basis” (p. 1392). While even the slightest of infection, injury, or minor 
surgery may trigger the body’s inflammatory response, without the protective barrier of 
pain being present, diabetic patients with sensory impairment are at greater risk of further 
injury, and early recognition is crucial (Kaynak, Birsel, Guven & Ogut, 2013). 
Another valid argument derives from a literature review by Milne et al. (2013), 
which discussed suggestions to assist healthcare providers in making early diagnoses of 
Charcot foot, choosing the appropriate treatment regimen, and reducing the incidence of 
further complications including amputations, sepsis and death. “Charcot neuroarthropathy 
(CN) continues to be a persistent challenge for clinicians, especially in its acute phase. 
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The report indicated that the diagnosis of CN is missed in as many as 79% of cases and 
an accurate diagnosis can be delayed up to 29 weeks” (p. 9).  
According to Gouveri & Papanas (2011), accurate diagnosis of Charcot can often 
be challenging. The authors stress the significance of patient and physician awareness as 
a means to obtain a prompt diagnosis and reduce the incidence of foot complications. 
“Charcot arthroneuropathy is a potentially limb-threatening condition which, beyond the 
emotional and social burden of physical dysfunction, has been associated with increased 
mortality” (Gouveri & Papanas, 2011, p. 59). In addition, the article contains five 
practical point recommendations for clinicians to aid them in early detection and 
management. They include:  
 Charcot should be ruled out in every diabetic patient with impaired sensory 
perception, regardless if the diagnosis is only a suspicion.  
 Immediate off-loading is recommended; if plain x-rays are negative, this 
should not delay off-loading.  
 Patient and physician education regarding early detection is essential.  
 Ulceration or infection in the plantar aspect of the foot should be avoided and 
if surgical intervention is required, a podiatric specialist should be consulted.  
 A detailed foot assessment and documentation utilizing a specified assessment 
tool, which follows ADA guidelines by a skilled practitioner, is recommended 
for all diabetic patients. 
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Finally, according to Jackson (2011), many diabetic patients with existing 
neuropathy may present with other distracting issues such as foot ulcerations, swollen 
extremities, or have no complaints of pain or discomfort at all; however, clinicians still 
have the responsibility to perform a thorough examination of the diabetic foot and must 
be skilled in their assessment techniques. Most complications of Charcot can be avoided 
with immediate treatment in the acute phase. While it is equally important to exclude 
other infectious processes or conditions such as deep vein thrombosis (DVT), “the 
overriding goal of treatment is to avoid amputation and prevent further deformity. Good 
outcomes can be managed with footwear that allows adequate gait and activity, thus 
sustaining overall quality of life” (Jackson, 2011, para. 21). 
Evidence-Based Practice Model 
The need for an assessment and screening tool for nurse practitioners, based on 
the increased risk of Charcot foot in the diabetic patient population, is an example of the 
Iowa model of evidence-based practice. This model begins with a trigger or identified 
problem, which may also be a knowledge-based problem. It involves the development of 
a team of stakeholders to develop, implement, and evaluate a practice change (Malone & 
Bucknall, 2013, 139). 
The Iowa model for evidence-based practice includes knowledge and problem 
triggers, which prompt providers to evaluate current practices as well as promote research 
when evidence is lacking (Rempher, 2006). “The Iowa Model of Research in Practice 
infuses research into practice to improve the quality of care, and is an outgrowth of the 
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Quality Assurance Model Using Research (QAMUR). Research utilization is seen as an 
organizational process. Planned change principles are used to integrate research and 
practice. The model integrates evidence-based healthcare acknowledges and uses a 
multidisciplinary team approach” (Mercy Medical Center, 2014, para. 8). 
According to a study by Varaei, Salsali & Heshmat (2013), the Iowa model was 
followed in a before and after design and involving 19 baccalaureate nurses who were 
currently working on an endocrinology unit in which the primary patient population 
consisted of diabetics with chronic leg ulcers. The focus of the study was whether 
evidence-based practice training courses could improve nursing skills. Results indicated 
trained nurses can prevent significant complications in diabetic patients including 
amputations and other adverse effects by means of early recognition and treatment 
interventions.  
This model has served as a reference for the project since the primary goal is 
directed at improving patient health and outcomes by identifying a trigger such as 
misdiagnosed Charcot foot, then integrating a multidisciplinary team to design an 
improvement plan such as assessment tool development and review of ADA policy and 
practice guidelines. “In this model, knowledge- and problem-focused triggers lead staff 
members to question current nursing practice and whether patient care can be improved 
through the use of research findings” (Titler & Moore, 2010, p. S3). Putting evidence into 
practice can be a complex process, but it is necessary for improvements in healthcare and 
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patient outcomes. The Iowa model has been a valuable resource in the project by 
providing a systematic process to identify and address an issue in diabetic health. 
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Figure 2. Iowa model of evidence-based practice 
Prevalence and Incidence 
The American Diabetes Association reports that approximately 60–70% of people 
with diabetes will develop peripheral nerve damage, which can lead to Charcot foot with 
an estimated 0.5% of those patients actually developing the condition. In most cases, the 
onset occurs after the age of 50 and in those patients who have been diagnosed for 15 to 
20 years (Peng & Swierzerswki, 2011). 
Despite the fact that uncontrolled diabetes and loss of proprioception is the main 
contributing factor leading to Charcot, researchers now believe other predisposing 
elements may increase the risk such as widespread atherosclerosis, inflammation caused 
by minor injury, infection, ulceration, or any other disorder in which blood flow is 
impeded (Kaynak et al., 2013). Discovering the underlying etiology is a crucial aspect in 
successful treatment.  
The incidence and prevalence of Charcot is not known exactly but is estimated 
that approximately 0.8-8% of the diabetic population are affected. The number is 
increased up to 10% when radiographic studies are used in diabetics with neuropathy. In 
addition, studies have shown men and women are equally affected and typically have had 
diabetes for at least 10 years and are between the ages of 50-70 (Gouveri & Papanas, 
2011).  
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Impact of Charcot Foot 
Charcot is a devastating complication of diabetic peripheral neuropathy and not 
only may affect a person’s physical appearance and their ability to work; it also has the 
potential of having a significant effect on their mental capabilities. Patients are often left 
with feelings of depression, guilt from financial strains, and isolation. In addition, 
patients suffering from Charcot experience a high rate of depression and anxiety due to 
physical mobility restraints and chronic pain. Male patients are even more at risk of 
complications due to an inability to work and provide for their families financially 
(Chapman, Shuttleworth & Huber, 2014).  
Finally, studies show that mortality rates of individuals with Charcot foot are 
significantly higher than those who have simple diabetic foot ulcerations and also those 
with type 2 diabetes not suffering foot complications at all. The comparable rates are 
28.3, 37.0, and 18.8% (Sohn, Lee, Stuck, Frykberg & Budiman-Mak, 2009).  
Risk Factors 
There are a variety of risks factors associated with the development of Charcot 
arthropathy and occur in patients with peripheral neuropathy resulting from diverse 
conditions including diabetes mellitus, leprosy, syphilis, poliomyelitis, chronic 
alcoholism or syringomyelia. Repetitive microtrauma that exceeds the rate of healing 
may also cause fractures and dislocations as well as changes in circulation causing 
resorption of bone, weakening the bone and increasing susceptibility to fracture and 
dislocation” (American Orthopedic Foot & Ankle Society, n.d.). Other contributing 
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factors may consist of sprains or other injury, which goes unnoticed as a result of sensory 
impairment. Continued pressure on the foot while walking may worsen the extent of the 
injury with subsequent dislocation or fractures in one or more bones of the foot or ankle.  
Signs and Symptoms 
Symptoms may include: foot deformity with elevated arch; foot drop, which is an 
inability to hold the foot horizontal); “slapping" gait (feet slap on the floor when walking 
due to foot drop); muscle atrophy in the lower extremities, leading to thin calves; 
numbness in the feet; balance or gait instability; later, similar symptoms may also 
develop in the arms and hands; joint dislocation; heat insensitivity in the foot; joint 
instability; erythema; bounding pulses; edema of the foot and ankle (caused by leakage of 
synovial fluid from the joint capsule); and subluxation (bone misalignment from a joint). 
Complications 
If left untreated or misdiagnosed, further serious complications may develop for 
the patient and include the following: ulcerations, especially if foot deformity is present 
or if there is a delay in diagnosis during early stages, calluses, bony protrusions (these 
have a greater risk of infection if friction persists for an extended period on the inner 
portion of the shoe), compression of blood vessels and/or nerves, osteomyelitis (bone 
infection), impaired or loss of sensation in the foot, and loss of foot function.  
Prevention 
To effectively prevent the formation of Charcot, patients in the diabetic 
population, or any person with peripheral neuropathy, should follow a strict foot regimen 
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including daily inspection in an effort to reduce the incidence of foot, metatarsal, and 
lower extremity amputation. This regimen consists of daily foot self-exams, wearing 
closed toed shoes at all times, avoid going barefoot (even indoors), seeking medical 
attention immediately if any open sores, injury, or changes to the appearance of the foot 
or ankle, keeping feet clean and dry, and avoiding moisture. Referral is also a key 
component in preventing Charcot. Patients considered being at high risk for developing 
ulceration, infection, and Charcot arthropathy deformities should be referred to a group of 
specialists who focus on mechanical, medical, and surgical intervention in the treatment 
of the diabetic foot and lower extremity ("Charcot Foot | Charcot Foot Information | 
Charcot Foot Treatment | Charcot Foot Prevention | Charcot Foot Symptoms," n.d.) 
Treatment 
Presently, there are numerous treatment methods available for treatment of 
Charcot foot with the primary goal being joint stabilization. Although there are currently 
no known treatments to stop or slow the progression of Charcot foot, research efforts 
continue in hopes of finding a solution. Recovery period may extend upwards of eight 
weeks or longer in the acute stage, during which time patients will be required to be non-
weight-bearing. Treatment options for non-surgical interventions include: 
 Immobilization 
 Custom shoes and bracing 
 Use of crutches, casts, and wheelchair used to protect foot 
 Limiting activities that cause the condition 
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Although surgical treatment is an option, treatment is primarily nonoperative due 
to the added factor of diabetes associated poor wound healing. Conservative treatment of 
Charcot foot relies on halting the destructive phase of progression, and then protecting 
and supporting the joints throughout the healing process. Other activities to assist in 
maintaining muscle strength include physical and occupational therapy, as well as 
physical activity directed toward improving independent functioning. Treatment plans 
can be broken into two phases, acute and post-acute.  The acute treatment phase is 
considered the onset until Charcot is inactive, which is 3-6 months after onset. Also, 
immobilization is recommended to prevent further destruction. The goal in the treatment 
of Charcot foot is intended to offload the foot, treat bone disease, and prevent further 
injury. Offloading during the active acute stage of Charcot is the most crucial 
management strategy and could prevent further progression to deformity, according to 
ADA recommended guidelines. 
American Diabetes Association Recommendations 
Since Charcot foot in the diabetic patient poses many clinical diagnosis and 
management challenges, the American Diabetes Association [ADA] task force met in 
2011 and created recommendations for appropriately managing this devastating lower 
extremity complication of diabetes, which is serious and potentially limb-threatening. 
The ADA recommendations are based on expert opinion and are as follows. They are 
available for access in Diabetes Care (Rogers et al, 2011). 
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Diagnostic Recommendations for Active Charcot Foot 
• Diagnosis of active Charcot foot is based primarily on clinical assessment and 
patient history but should be confirmed by imaging. 
• The earliest clinical manifestation is inflammation, which is an important 
aspect in the pathophysiology of Charcot foot. 
• Despite absence of deformity, Charcot foot is considered to be acute and 
active in sensory impaired individuals with foot or ankle fractures or 
dislocations due to the inflammatory process of bone healing.  
• Initial radiologic imaging should be performed and healthcare providers are 
urged to observe for subtle or underlying fractures or subluxations, regardless 
of without obvious visible pathology. 
• Clinical suspicions may be confirmed with MRI or nuclear imaging in the 
presence of normal-appearing radiographs. 
Recommendations for Medical Therapy 
• Foot offloading and immobilization are the most vital treatment 
recommendations in active Charcot foot and have the potential of preventing 
further destruction. 
• Little evidence is available to guide in the use of available pharmacological 
therapies to promote healing of Charcot foot. 
• Weight-bearing devices such as braces, prescription shoes, boots, or other 
protective measures are required post active occurrence 
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• Lifetime monitoring is advised to monitor for diabetic foot complications or 
recurrence or new signs of Charcot foot. 
Summary 
The severity of untreated or misdiagnosed Charcot foot can lead to potentially 
life-threatening and or life changing complications. Patients are left with significant and 
devastating alterations to their body and endure substantial financial costs. Individuals 
with peripheral neuropathy have even higher rates of mortality than persons without 
ulcerations than type 2 diabetics with intact peripheral sensation. Charcot is a major 
health issue affecting an infinite number of patients each year, many of whom have never 
heard of it and are unaware of its overwhelming and destructive potential. Prevention and 
early detection are the keys to avoiding such effects.  
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Section 3: Approach 
Introduction 
The purpose and goal of this quality improvement project was to develop an 
assessment and screening tool to assist healthcare providers in the early detection, 
diagnosis, and treatment of Charcot foot in the diabetic population. This project included 
the target population of adult type 2 diabetic patients who have been diagnosed for at 
least ten years, been treated with either oral hypoglycemic or insulin therapy, and either 
have or are at risk of having peripheral neuropathy. Also included were those patients 
with a history of or currently being treated for any type of foot ulceration, wound, injury, 
or complaints of foot or ankle pain, and patients who have a documented change of foot 
appearance. Stakeholders for this project were the patients, private insurance carriers, 
Medicare and Medicaid, podiatrists, and healthcare practitioners who provide care to 
diabetic patients. Accomplished project development activities are outlined as listed 
below. 
The steps in the process of this project were as follows:  
1. Assemble interdisciplinary project team with various stakeholders guiding the 
project; 
2. review best practices of diabetic foot assessment as presented in evidence-
based literature; 
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3. integrate ADA policies and practice guidelines for the assessment, treatment, 
and referral of the diabetic patient with, or at risk for developing, Charcot foot 
in conjunction with the project team; 
4. develop an assessment and screening tool of the diabetic foot in conjunction 
with the project team; 
5. develop an implementation plan in collaboration with the project team; and 
6. develop an evaluation plan in collaboration with the project team. 
Rationale 
I assembled an interdisciplinary project team of community stakeholders 
interested in supporting interventions to improve assessment and prevention of Charcot 
foot in diabetic patients with peripheral neuropathy. Invited stakeholders included nurse 
practitioners, diabetic educators, podiatrists, and health information specialists. A 
literature review was conducted to identify current best practice on how to develop, 
implement, and evaluate policy and practice guidelines, and this information was shared 
with the project team. In addition, a meeting was conducted to inform members of the 
Texas Panhandle Nurse Practitioners Group of the proposed project. During the meeting, 
I solicited members of various clinics, such as medical directors, to participate in the 
advisory group to support the creation and sustainment of the policies and guidelines.  
From the project team and meeting, stakeholders were identified from various 
groups to compose an advisory group, which aided in the development of an assessment 
tool and its implementation and evaluation. “For a number of reasons, it is necessary to 
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involve or consult with appropriate community members at the very beginning of the 
program planning process and to include them on an advisory panel or planning 
committee. As with the needs assessment process, target population and stakeholder 
involvement is necessary during the planning and implementation stage” (Hodges & 
Videto, 2011, p. 109).  
Advisory committee members consist of individuals who offer expert skills and 
unique knowledge, which strengthen the expertise of the board of directors as a means of 
guiding the organization more effectively. They offer expert opinions and suggestions, 
provide diversity, and offer fresh perspectives on programmatic issues (National 
Abandoned Infants Advisory Resource Center, n.d.) One factor that facilitated the 
development of an interdisciplinary team who supported the assessment and treatment of 
Charcot foot was that of continuous community input via stakeholder engagement. 
Stakeholder feedback and input is an integral part of any successful healthcare program. 
Stakeholders offer valuable insight such as suggestions on plan development, and they 
assist in setting strategic direction, goals, and performance targets (Curran & Totten, 
2010). A review of the literature, in conjunction with feedback from project team 
members, stakeholder input, and continued engagement through means of email follow 
up and NP website discussion postings can increase the likelihood of program success.  
Interdisciplinary Project Team 
The multidisciplinary team consisting of five members was invited to participate 
in the project based on their knowledge and expertise in the area of diabetes and 
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management of complications. Disciplines included diabetes education, nurse 
practitioner, podiatry, IT computer personnel, and nursing informatics. Members were 
selected for their knowledge and experience in treating diabetic patients and their medical 
specialty in podiatric medicine, computer technology, and informatics. Each member 
reviewed the policy and practice guidelines regarding the early detection and intervention 
of patients at risk of Charcot foot as well as appropriate treatment regimens. Utilization 
of valid resources such as medical specialists and those having experience in one 
particular area is beneficial for ensuring all essential elements are included in the plan 
design. According to Nancarrow et al., (2013), interdisciplinary teamwork is “a dynamic 
process involving two or more health professionals with complementary backgrounds and 
skills, sharing common health goals and exercising concerted physical and mental effort 
in assessing, planning, or evaluating patient care” (p. 2). 
Reviewing Evidence 
The interdisciplinary team members each received a copy of the goals and 
objectives for the project prior to development of an assessment tool and were led 
through the review of scholarly literature. Furthermore, a Gannt chart was dispersed to 
each member to illustrate the incidence of Charcot foot along with information obtained 
from the American Diabetes Association as well as the American Podiatric Medical 
Association. All of the above was provided during an initial meeting with the 
interdisciplinary team. 
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Implementing Policies and Practice Guidelines 
According to the 1992 Institute of Medicine (IOM) report, clinical practice 
guidelines, are among the foundations in which to improve healthcare through 
systematically developed statements that are meant to assist the practitioner, as well as 
the patient, in decision-making regarding suitable healthcare for specific clinical 
circumstances. This process involves problem identification, evidence assessment, 
translation of the evidence, and implementation into clinical practice guidelines, followed 
by evaluation and revision as necessary (Woolf, Schünemann, Eccles, Grimshaw & 
Shekelle, 2012). 
Charcot foot continues to be a complicated and complex diagnosis that remains a 
clinical challenge for practitioners. As a result of the number of missed cases of Charcot 
foot, in as many as 79%, most clinical guidelines available do not involve a rigorous 
evidence-based process (Milne et al, 2013). Therefore, development of a screening tool 
and algorithm will require input from multiple experts. Although not all diabetic foot 
complications are preventable, it is possible to drastically lessen the incidence through 
proper management and prevention platforms. “The multidisciplinary team approach to 
diabetic foot disorders has been demonstrated as the optimal method to achieve favorable 
rates of limb salvage in the high-risk diabetic patient” (Frykberg et al, 2006, p. S49). 
Although there is no specific cure for Charcot foot, the goal in developing policy 
and practice guidelines will be directed toward early detection, accurate diagnosis, 
immediate initiation of treatment, and the referral process. Despite the fact that healthcare 
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professionals are ultimately responsible for identifying patients at highest risk of Charcot 
foot and completing an extensive and thorough assessment, the fact remains that patients 
themselves are responsible for adhering to treatment regimens and following up with 
referred specialists; for that reason, patients will be encouraged to be an active participant 
in their care. 
Content Validation 
Content validation in the area of Charcot foot is essential in order to go forth with 
the development of policy and practice guidelines. One method of validation is the 
computation of a Scale Content Validation Instrument (S-CVI) with two expert raters for 
a 10-Item scale, which is defined by Polit & Beck (2006) as the proportion of items given 
a rating of quite/very relevant by both raters involved. This particular method allows the 
entire scale of items, up to 10, to be ranked by the raters as valid and relevant by the two 
experts and the proportion of total items judged content valid. Appendix A is an example 
of this type of scale.  
Implementation Plan 
Following Internal Review Board (IRB) approval by Walden University, the 
proposed assessment tool was developed by the project team for later implementation 
with the nurse practitioner community in Northern Texas where there are currently 65 
members of the Texas Panhandle Nurse Practitioners Association (TXPNPA). The 
assessment tool was distributed only to practitioners who are the primary care giver of 
adult type 2 diabetic patients. Part of the implementation phase included written forms of 
31 
 
 
 
the assessment tool as well as the computerized version for those providers who have 
converted to electronic documentation. One benefit of utilizing the electronic medical 
record is the assessment tool will be a mandatory inclusion for providers, which will 
serve as an assessment reminder and hopefully reduce the number of undiagnosed cases. 
The computerized health information system being utilized at the health clinic has the 
capability of revisions to assessment templates and will be maintained by the clinic’s 
computer personnel. These plans were presented to the project team for consideration and 
refinement. The final DNP Project included an implementation plan developed by the 
project team.  
Evaluation Plan 
The evaluation plan development transpired after implementation planning and 
was included as an appendix in the final DNP project paper. Evaluation was scheduled 
after a 3-6 month assessment trial period to include key stakeholders of the project, nurse 
practitioners in the Texas panhandle. The project team was the ultimate authority on 
development of the evaluation plan and the following is the plan for evaluation that was 
presented to the stakeholders as an integral part of this DNP project. The evaluation plan 
for this project involved both a verbal and written formal process in the form of an 
electronic anonymous survey. The focus of the evaluation was on the overall opinion of 
the form as an effective means of assessment for the diabetic patient, ease of completing, 
inclusion of pertinent focus areas, and appropriate referral documentation if needed.   
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Financial Considerations 
Budget is one of the most principal aspects to consider when developing a health 
program. Finding the most appropriate resources for the target population often means 
the planner must endure certain costs to ensure the highest quality services. Financial 
considerations for this project included the utilization of resources such as computer 
system IT personnel to load and maintain the EMR assessment tool. Each clinical setting 
is equipped with computer equipment, which was in place prior to this project. For those 
healthcare settings who do not have access to a computer based system, the financial 
costs associated with this project were minimal and involved ordering of a paper form of 
the assessment tool.  
Ethical Considerations 
Ethical considerations are essential for all members of the healthcare team. Nurses 
have a responsibility to care for all patients, regardless of race, age, gender, national 
origin, religion, or ability to pay for care. Diabetes is a serious health problem for many 
Americans and affects a broad cultural diversity of individuals such as African 
Americans, Asian and Pacific Islanders, American Indians, Hispanics, and Alaskan 
Natives. Several of these individuals have little or no insurance coverage or access to 
healthcare; therefore, are at an increased threat of acquiring problems such as Charcot 
foot. Another issue is the cultural diversity of patients in today’s society. For these 
reasons, ethical considerations for the development of an assessment tool included 
awareness of healthcare providers in the areas of culture, financial, and even access to 
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transportation. “The code of ethics for the American Association of Diabetic Educators 
(AADE) urges diabetes educationalists to “respect and uphold basic human rights”, and 
“respect the uniqueness, dignity, and autonomy of each individual” (“Cultural Sensitivity 
and Diabetes Education”, 2012). 
IRB approval ensuring that the project complied with the university’s ethical 
standards and federal regulations was obtained from Walden University, IRB approval 
number 02-20-15-0357309, and permission was given to move forward with the project 
after an oral proposal defense.  
Summary 
Prevention of Charcot foot is an important aspect of assessment in the diabetic 
population and more importantly, in patients suffering from peripheral neuropathy. The 
ability to rapidly and accurately identify risk factors, signs and symptoms, and 
appropriately treat this serious complication of diabetes is a significant measure in 
preventing life-threatening injuries to patients’ feet and ankles. Following 
recommendations set forth by the American Diabetes Association holds the responsibility 
of every healthcare provider who cares for the diabetic patient and an accurate focused 
assessment is a key factor of this care. Development of an assessment tool not only 
assisted practitioners in this feat but has the potential to prevent devastating life-long 
effects for the patient as well.  
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Section 4: Findings, Discussion, and Implications 
Introduction 
While the project was developmental, no research was conducted, and it did not 
include patient involvement. The purpose of this DNP scholarly project was to assist 
nurse practitioners in the early detection, treatment, and referral of Charcot foot in type 2 
diabetic patients. I developed an assessment and screening tool based on the American 
Diabetes Association’s (2011) recommendations that could be utilized in the clinical 
setting and integrated into the patient’s electronic medical record. In addition, a screening 
algorithm and assessment and treatment practice guidelines were created for adjunct 
purposes. 
Focus points on the assessment were derived from key features of the foot, which 
included monofilament points, evidence of outward physical abnormalities, and severity 
of peripheral neuropathy. Monofilament testing, otherwise known as Semmes-Weinstein 
monofilament exam, contains “5.07 monofilament nylon wires exert 10 g of force when 
bowed into a C shape against the skin for 1 second. Patients who are unable to reliably 
detect application of the 5.07, 10-g monofilament to designated sites on the plantar 
surface of their feet are considered to have lost protective sensation” (Morgan, 2013, 
para. 2). The assessment and screening tool also included a recommendation for annual 
follow up or podiatric referral based on findings of the examination by way of a 
screening algorithm. Finally, assessment and treatment practice guidelines were 
developed to utilize at clinical or primary care sites. 
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Summary and Evaluation of Findings 
Due to the potential life threatening complications of type 2 diabetes and the 
complexity in diagnosing Charcot foot, it is imperative that healthcare professionals, such 
as nurse practitioners, be educated and competent in their assessment skills. According to 
the U. S. Department of Health and Human Services Health Resources and Services 
Administration Bureau of Health Professions Division of Nursing; (2002), “the adult 
nurse practitioner employs evidence-based clinical practice guidelines to guide screening 
activities, identifies health promotion needs, and provides anticipatory guidance and 
counseling addressing environmental, lifestyle, and developmental issues” (p. 17). 
Providers must maintain a degree of proficiency to support detect and treat all major 
disease complications.  
I presented the assessment and screening tool, assessment and treatment practice 
guidelines, and screening algorithm to members of the Texas Panhandle Nurse 
Practitioners Association at the Annual NP Conference, which included my practicum 
mentor. Paper copies were dispersed during this time and members were allowed the 
chance to ask questions and offer comments and suggestions immediately following. 
There were several practitioners who voiced a need for clarification regarding 
monofilament testing as well as a request to include the patient’s BMI on the assessment 
tool; these suggestions were later included.  
In addition, two content experts reviewed the tool using the Computation of an S-
CVI for a 10-Item Scale with Two Expert Raters (Appendix A). Content experts included 
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a DNP-prepared nurse practitioner and a podiatrist. Revisions were made to the 
assessment tool to include BMI and specific monofilament testing results. The final 
revised assessment tool, screening algorithm, and practice guidelines are attached as 
Appendices B, C, D, and E.  
I have provided the practicum mentor with a final copy of each of the above 
mentioned forms as well, which can be integrated into the electronic medical record for 
use when screening the diabetic patient population at the practicum site.  
Discussion of Findings in Context of Literature 
After conducting an extensive literature search using databases such as CINAHL, 
Medline, PubMed, EBSCO, and Walden University library, I discovered a need to 
educate nurse practitioners as well as other healthcare providers in the severe and 
conceivable life-threating complications of Charcot foot in the diabetic populace. 
Through the use of evidence based practice, I identified the necessity for an assessment 
and screening tool to contribute to the prevention and early detection of Charcot foot and 
the immediate need of podiatric referral. The assessment tool is an excellent guide to 
support practitioners in the evaluation of high risk patients such as diabetics suffering 
from peripheral neuropathy. In today’s realm of healthcare, providers depend on various 
sources and experts to improve patient care through collaboration (Barry, 2015).  
Up until the mid-1990s, Charcot foot was thought of as a rare sensory deficit 
condition but experts later recognized it as a destructive process that led to 
immobilization to prevent further injury or trauma by imposing non weight-bearing until 
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the acute phase had been resolved (Veillette, 2016, p.99). Success of treatment is based 
on increasing awareness in practitioners who routinely provide care for the diabetic 
patient population. 
One particular study conducted by Botek et al. (2010) referred to a 53 year-old 
male who was misdiagnosed in the emergency department after presenting with multiple 
symptoms including pain, redness, and edema to the foot and ankle. This patient was kept 
in the hospital and received a course of IV antibiotics, then discharged home with oral 
antibiotics and instructed to follow up with his primary care physician. After being seen 
by the primary care physician (PCP) two to three additional times, the patient was 
eventually referred to an orthopedic specialist and diagnosed accurately with Charcot 
foot, but the damage suffered to the foot and ankle was irreversible at that point.  
Estimations are that 0.1 to 5% of all diabetics will acquire Charcot foot at some 
point during their disease with an increase in odds for those suffering from end-stage 
neuropathy. Furthermore, those patients having foot sores or ulcerations are more prone 
to require limb amputation; therefore, “it is extremely important for the foot and ankle 
specialist to judiciously approach the Charcot joint” (Bernstein, Ritter & Diamond, 2012, 
pg. 2).  
Another study consisted of two groups of patients. Group 1 was comprised of 
eleven patients diagnosed within one month of onset of Charcot symptoms while Group 2 
consisted of thirteen patients, all being diagnosed within three months of onset. Both 
groups were treated immediately upon diagnosis with non-weight-bearing measures; 
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however, the study found those in Group 1 were only immobilized for a time period of 3 
months as opposed to those in Group 2 who had to remain immobilized for a total of 5 
months. The delay in diagnosis and treatment had a substantial impact on the patients’ 
outcomes. All participants in Group 2 advanced to fracture of the foot and resulted in 
rocker bottom foot deformities (Schade & Anderson, 2015). The ultimate goal of acute 
Charcot of the foot and ankle is early detection and stabilization to minimize the risks of 
infection, ulcerations, calluses, and amputation. 
According to O’Rourke (2010), a total of 3,445 patients who had either an above 
or below the knee amputation were included in a study over a period of nine years. Over 
60% of the patients had peripheral neuropathy from diabetes, trauma, or other 
complication of Charcot foot. The study showed that healthcare professionals, including 
nurse practitioners, were among those who did not recognize potential issues, which 
delayed care and led to amputations.  
As a result of impaired peripheral sensory neuropathy in patients suffering from 
type 2 diabetes, patients may have no specific recollection of injury. The initial indicator 
of Charcot foot may include an abrupt alteration in the appearance of the foot or ankle 
and or discoloration (Sanders, 2014). Therefore, patients often delay seeking medical 
treatment due to vague symptoms or being unaware they have sustained any type of 
injury.  
The current literature supports the need for further education and assessment tools 
to aid in the correct diagnosis and treatment referrals for patients who are at higher 
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probability of Charcot foot. It is imperative that practitioners be given every means of 
identifying these patients and intervening before life threatening complications occur. 
Currently, there are various advanced assessment tools available, but they are directed 
toward the advanced specialist skills. This project assessment tool will serve as a user 
friendly assessment tool for nurse practitioners to assist in the early detection and 
prevention of complications such as Charcot foot and as a guide in the next step of 
treatment options. 
Implications for Practice 
Due to the rarity and often overlooked complication of peripheral neuropathy 
known as Charcot foot, diagnosis and treatment poses a critical issue for healthcare 
practitioners, including nurse practitioners (Rogers et al, 2011). Therefore, an assessment 
tool is needed to serve as a guide for nurse practitioners to assist in the early recognition 
and treatment and to prevent further complications and possible loss of limb.  
Nurses have a vital responsibility in helping to prevent foot ulcers and 
amputations through means such as education, screening high-risk populations, and 
assessment and intervention. Foot care education is crucial for all diabetic patients but 
more so those at an increased risk due to neuropathy. Nurses can encourage and teach 
patients how to perform daily foot exams as well as consequences of untreated wounds or 
delay in care. According to the WHO, diabetes is becoming an epidemic in most 
countries; therefore, evidence demonstrates that the burden of helping to avoid to 
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significant consequences lie on both healthcare providers as well as communities as a 
whole (Aalaa, Malazy, Sanjari, Peimani, & Moharjeri-Tehrani, 2012).  
Diabetic foot complications are foremost contributors to greater morbidity and 
mortality rates. Without obvious signs of inflammation such as warmth, erythema, or 
function deficit, it is a significant challenge for healthcare providers to diagnose Charcot 
foot. “Foot complications in people with diabetes can be difficult to treat and 
conventional therapies often fail, leading to amputations; thus, prevention of this 
condition is of paramount importance” (Houghton, Bower & Chant, 2013, p. 1). 
Advanced practice nurses must be willing to accept continuous new evidence and tools 
that will improve patient outcomes as an integral part of their practice. Patients rely on 
the knowledge and skill of healthcare professionals to ensure their well-being and 
positive outcomes. Assessment is a key element of the nursing role for all patient 
populations but more so for those individuals suffering from major diseases such as 
diabetes or other causes of peripheral neuropathy. The American Diabetes Association 
reports that 60–70% of people with diabetes are affected with peripheral nerve damage, 
which can advance to Charcot foot, and approximately 0.5% of these patients will 
progress to Charcot. This data is especially relevant to nursing practice and advanced 
assessment skills. 
Implications for Social Change 
Diabetic neuropathy is considered the most frequent complication of type 2 
diabetes mellitus and affects generally 50% of all diabetic patients. As stated by the 
41 
 
 
 
American Diabetes Association [ADA] (2013), type 2 diabetes has the potential for 
severe systemic complications, such as peripheral neuropathy, which is likely to lead to 
devastating injuries. Due to the loss of sensation, patients are often unaware of wounds or 
other abnormalities and therefore; delay seeking treatment. Due to the rarity of Charcot 
foot, healthcare providers often dismiss or overlook this serious complication and initiate 
other forms of treatment. According to Fowler (2007), “current statistics indicates 
diabetes will continue to affect the United States population for the foreseeable future and 
is by no means limited to the United States” (p. 42). Additionally, the complications 
associated with this disease will also continue to be prevalent among those affected and it 
is the responsibility of providers to seek resources to assist them with accurate and 
appropriate diagnoses and treatment options. 
As with many other chronic health conditions, the social and mental aspects of 
type 2 diabetes can be devastating for patients, families, and care givers alike. Diabetic 
treatment regimens must be maintained on a daily basis, despite social pressures, 
economic status, or distracting life events (Welch, Jacobson & Weinger, 2008). While 
type 2 diabetes typically develops or manifests in middle adulthood, this may 
significantly influence motivation to seek treatment and may require greater efforts or 
willingness to change. Even in the early phase, subtle complications such as foot calluses 
may appear to be minor and unimportant for the diabetic patient, thus delay in seeking 
treatment.  
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Other facets to consider are the costs of medical management, wound care, 
potential vascular interventions, infection control, wound closure, off-loading, and 
alternative and adjunctive therapies. The primary preventative goal is tight glycemic 
control and includes patient monitoring of blood glucose levels in addition to periodic 
hemoglobin A1C levels. The cost of diabetic testing supplies can be overwhelming for 
many people who do not have access to healthcare coverage. In addition, once an 
ulceration or infection has occurred, management of these wounds can be difficult to treat 
and may require numerous and lengthy treatment options. Furthermore, once aggressive 
therapy has been initiated, weight bearing is often limited or may necessitate complete 
offloading of the foot.  
Socioeconomic issues begin with extensive healing. For patients who are unaware 
of an injury, which progresses to an ulceration, “the average cost of treatment ranges 
from $3609 to $27, 721” (Sumpio, 2012, p. 13). Regardless of whether a patient is in 
need of complex therapy over an extended period of time or is simply required to be in 
some form of offloading device during the acute phase of Charcot foot, the potential for 
financial strain is inevitable.  Complications of diabetic foot conditions are typically 
debilitating to patients, families, and caregivers alike. Patients are often times unable to 
continue working and have to rely on others or governmental assistance programs to 
sustain their daily lives. Others who are permanently disabled are forced to file for long-
term social security disability, which is an extremely long and drawn out process that 
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may or may not be approved initially. For those who gain approval, the length of time for 
their first payment is typically six to seven months.  
As stated previously, early detection is vital in advancement to further injury and 
reduce the incidence of long-term or permanent disability. The development of an 
assessment and screening tool specific to the diabetic foot is one method of ensuring 
early detection and intervention, following ADA recommended guidelines for treating 
Charcot foot.  
Project Strengths, Limitations, and Recommendations 
The strengths of the assessment tool include the outlined specific areas of the foot 
to be assessed and inclusion of any identified abnormalities. Also, a section exists for 
pertinent patient data to be considered such as latest HgA1C levels, which indicate 
controlled or uncontrolled blood glucose levels over a three month period. This data is 
especially important since this directly relates to progression of healing. Additionally, the 
tool contains instruction for further treatment or referral based on the assessment 
findings.  
Limitations of the project involved an initial negate by one practitioner to accept 
the terminology of Charcot foot but rather felt it was simply a complication of diabetes 
and felt it could be treated as such. After further education and the development of the 
assessment tool, which was presented at the annual nurse practitioner symposium, the 
project and tool were more widely accepted. Additionally, various other advanced 
practice nurses have since voiced an interest in gaining information on how to perform a 
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more structured foot and ankle examination on their diabetic patient population. The 
interest has been from practitioners within local acute care settings as well as community 
clinics. 
Recommendations for the project were made by members of the area nurse 
practitioners and consisted of the addition of BMI (body mass index) and specific 
interpretation of monofilament points to the assessment tool.  
Analysis of Self as a Scholar 
Throughout this journey, I have learned so many things about myself, not only as 
a person but as a contributing academic scholar. I have grown exponentially in the areas 
of professionalism, academic peer, clinical specialist, and hope that my contribution to 
the diabetic patient population will have a positive effect on patient outcomes. Although 
this was a long and sometimes tiring feat, I have remained steadfast on my path to a 
doctoral degree. As an educator, I have also learned to be more detail oriented and know 
that whatever experience and knowledge I can offer will hopefully have a lasting 
impression on the careers of my students. They rely on me to be knowledgeable on the 
content I present to them in order for them to be successful . Remaining current on 
evidence based practices and having a desire for knowledge will have a direct impact on 
patients whether it be at the bedside or through experiences shared with students or 
novice nurses. Lastly, I have gained confidence in myself as a nurse and scholar and will 
be eternally grateful to my mentors, peers, fellow students, and professors for seeing me 
through this process. 
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Analysis of Self as a Practitioner 
Confidence is a word that comes to mind when I think about myself as a 
practitioner. When I began as a novice nurse over twenty years ago that was a descriptor I 
never believed would be a part of who I was as a nurse. I was withdrawn, timid, and 
fearful of making mistakes. Although I had received the same education as my peers, I 
was lacking confidence as a practitioner. However, as time went on and I was forced to 
step up and advocate for my patients, I could visibly see a difference in myself. I knew I 
had to be the voice for those who could not speak for themselves. Despite this newly 
gained confidence, I was unaware of what was missing. The years of experience of 
practicing in the emergency department had exposed me to a vast array of situations that 
would expand my knowledge of diseases, trauma related injuries, skills, and treatments, 
but little did I know it I was not practicing holistic nursing. 
Without the DNP program at Walden University, I believe I was confident and 
even competent in the skills and tasks I was performing, but did not realize there was so 
much more I needed to learn until I reached this point in my career. The DNP path has 
given me a new feeling of confidence in myself as a person and a practitioner. 
Assessment was always a skill I felt I possessed but throughout the scholarly progression, 
I came to realize there was so much more to learn. The entirety of my career had been 
based on the premise of short term interventions that would provide a temporary stability 
until definitive treatment could be attained elsewhere. I value the time I spent in the 
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emergency department all these years but my view of what patient care really was had 
been distorted.  
My goal after attaining an advanced education is to deliver the utmost quality of 
care to my patients and improve overall quality of life through prevention, anticipating 
patient needs, and integrating advanced practices into patient care. 
Analysis of Self as Project Developer 
An integral part of the project was the use of literature review as a means of 
incorporating evidence based practices into patient care through the development of an 
assessment tool for use by nurse practitioners to assist in the early identification of 
Charcot foot. In collaboration with my mentor, I recognized a need for further education 
and design of a tool that would is easy to follow and would adhere to ADA 
recommendations. In addition, I utilized content experts such as diabetic educators, 
podiatry, and a nursing informatics specialist to assist with the project. As an integral part 
of the process, I have taken into consideration the vast amount of recommendations and 
assessment techniques from various podiatric specialists who are experts in their fields 
and have treated patients with Charcot foot. Once I had gained a sense of the current need 
and gained knowledge on this topic, I was able to develop the tool and present it to areas 
nurse practitioners for further input.  
Throughout the development process, a majority of the inspiration came from 
personal experience with my husband who suffers from Charcot foot due to the effects of 
type 2 diabetes and peripheral neuropathy. The delay in diagnosis was in part due to the 
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severity of sensory deficit in his feet but also due to the lack of knowledge on the part of 
the practitioner who was treating him for a simple nondisplaced foot fracture. After 
several long months of seeing no improvement and the edema continuing, the inevitable 
happened and he incurred full blown Charcot foot. I as a practicing member of the 
healthcare team, had not been exposed to this condition before and was not something I 
learned throughout my nursing education; therefore, I was unaware of the severity of his 
condition until we sought treatment from a podiatrist specializing in diabetic foot 
conditions. The delay in diagnosis had resulted in permanent deformity of his foot and he 
underwent and extended acute phase in which he was placed in a correct offloading boot 
until the remodeling phase was completed. The physical and mental trauma he had 
endured was just beginning and would carry forward with him as an everlasting reminder. 
I found myself being left with feelings of inadequacy as a practitioner and felt as though I 
should have recognized the manifestations and intervened sooner. This turn of events is 
what inspired me to dedicate the DNP project to early detection and prevention for other 
diabetic patients.  
Despite the amount of time this project entailed, the reward was the overall end 
project, which was an assessment and screening tool that would be utilized in the care of 
diabetic patients and could potentially save at least one person from suffering from the 
devastating effects of Charcot foot. I have learned that with persistence and dedication, I 
can make a contribution to the outcome of patients in the future and also that I have the 
ability to make a difference. One of the single most important aspects of this project was 
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the continued support from my professors and my mentor who provided me with valuable 
feedback and encouragement.  
Analysis of Self as a Professional 
Of all my years in nursing, I feel more of a professional and contributor than ever 
before. Despite the various roles and titles throughout my career, my role as an educator 
and scholar is the most important. I have a long road ahead of me regarding contribution 
to the academic world, but I know the end result will be a sense of gratification in 
knowing I had an impact on someone’s life and will be respected in my field. In spite of 
the fact that I have not yet reached completion, I have already gained a new respect from 
my peers and students. Regardless of what the future holds, I can honestly say I have 
made a difference. I am able to see proof of this through the eyes of students who have 
that aha moment when things start to come together or during graduation when I can see 
the growth and maturity from the day they entered the nursing program to being 
confident and ready to practice independently. My confidence has reached a new high 
and I look ahead to what the future holds. I plan to continue with expanding my 
professional horizons by publishing in various medical and nursing journals with the 
hope of having a positive effect in the nursing profession.  
Summary 
Charcot foot is a devastating and potential life threatening complication of 
diabetes and those suffering from peripheral neuropathy. As stated previously, many 
patients suffering from peripheral neuropathy or impaired sensory perception may 
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experience injuries that are unaware until they begin to see visible signs of trauma such 
as edema, discoloration, or deformity. For these reasons, patients often times delay 
seeking treatment or are treated by healthcare providers with little or no knowledge on 
the clinical manifestations of diabetic foot complications.  
If left untreated, Charcot foot may progress to permanent disfigurement or 
amputations. Early detection and intervention is the key to preventing this serious 
condition. The development of an assessment screening tool and following ADA 
recommendations will assist nurse practitioners and benefit the diabetic population. 
Currently, there are multiple assessment tools available to specialists in this area such as 
orthopedics and podiatry but are far more advanced than what is needed for early 
recognition and referral for advanced practice nurses. After receiving feedback regarding 
a need from local advanced practice nurses, I created an assessment and screening tool, 
along with screening algorithm, and assessment and treatment practice guidelines, as a 
means to assist them in the care of the diabetic patient population who are at risk due to 
peripheral sensory deficits. In doing so, the goal is for immediate intervention, treatment, 
and referral to podiatry specialty if warranted and prevent further damage or injury. 
Also, a lack of education regarding the rarity and complexity of Charcot foot was 
identified and therefore; the information was presented to area nurse practitioners at an 
annual conference, which is discussed further in the following section. 
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Section 5: Scholarly Project 
Introduction 
The DNP project is intended to improve patient care with the use of an assessment 
and screening tool and algorithm to aid in early identification of Charcot foot in the type 
2 diabetic patient populations. The project involves the identification of a practice 
problem and the completion of a project that will lay ground work for future scholarship. 
According to the American Association of College of Nurses (AACN) (2006), “doctoral 
education in nursing is designed to prepare nurses for the highest level of leadership in 
practice and scientific inquiry. The DNP is a degree designed specifically to prepare 
individuals for specialized nursing practice, and The Essentials of Doctoral Education for 
Advanced Nursing Practice articulates the competencies for all nurses practicing at this 
level” (p. 7) Assessment is a key element in nursing practice and this project addressed a 
need involving early identification of Charcot foot and referral for type 2 diabetic patients 
suffering from peripheral neuropathy.  
Problem Statement 
Diabetic neuropathy is the most prevalent complication of type 2 diabetes mellitus 
and affects equal to 50% of all type 2 diabetics. Peripheral neuropathy, or peripheral 
nerve damage, causes significant issues such as nonhealing wounds, major infections, 
amputations, and Charcot neuropathic osteoarthropathy (CN), commonly referred to as 
Charcot foot, which involves the soft tissue and bones of the foot and ankle and thus 
leads to permanent deformities. This may transpire if the bones in the feet suffer fractures 
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and the foot becomes misaligned.  Although experiencing a fracture would be extremely 
painful to most people, this particular condition can be painless to the diabetic patient 
since nerves were damaged from diabetes prior to the fracture. The foot or feet may 
subsequently lose muscle support, eventually converting to deformity. Diagnosis can 
sometimes be difficult due to the potential of mimicking other conditions like cellulitis or 
deep venous thrombosis, and because diagnosis of a Charcot fracture cannot be made 
definitively until bone changes occur. Therefore, the focused problem in the project was 
inconsistency of healthcare providers in the recognition and referral of patients with 
potential Charcot foot. 
Purpose Statement 
According to Lin and Lorenzo (2013), “in type 1 DM, distal polyneuropathy 
typically becomes symptomatic after many years of chronic prolonged hyperglycemia, 
whereas in type 2, it may be apparent after only a few years of known poor glycemic 
control or even at diagnosis” (para. 2) Symptoms affect sensory, motor, and autonomic 
systems of the body. When neuropathy progresses to Charcot foot, it becomes a serious, 
potential limb-threatening complication and during the acute phase, is considered to be an 
inflammatory syndrome. Due to the rarity of this condition, diagnosis and treatment poses 
a critical issue for healthcare practitioners including nurse practitioners (Rogers et al, 
2011).  For this reason, the intent of the project was the development of an assessment 
and screening tool, with integration of ADA recommendations, for nurse practitioners to 
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promote early detection and treatment of Charcot foot so as to avoid additional injury and 
possible loss of lower limb or foot. 
Goals and Outcomes 
The purpose of this project was to develop an assessment and screening tool and 
integrate recommendations set forth by the American Diabetes Association in an effort to 
assist nurse practitioners in the assessment, diagnosis, and treatment of Charcot foot in 
the diabetic patient with peripheral neuropathy. In doing so, the goal was to improve 
consistency of healthcare providers in the detection and treatment of patients with or at 
risk of Charcot foot.  
This section outlines the process by which an assessment tool was developed, 
along with implementation and evaluation. No data was collected nor were participants 
involved as the project involved the development of an assessment tool to further assist 
NPs in the early detection, identification, and treatment of type 2 diabetic patients at risk 
of Charcot foot.   
The outcomes that were used to determine goal attainment for the project included 
an evaluation planning step at the end of this DNP Project. The following outcomes were 
suggested as possible starting points for evaluation planning: 
Outcome 1: Healthcare providers will identify, assess, and treat patients with 
Charcot foot. 
Outcome 2: Healthcare providers will refer patients with Charcot foot to 
appropriate specialty for follow up care. 
53 
 
 
 
The detection of patient risks by nurses, which is “the ability of nurses to 
accurately identify signals can lead to early interventions so that harm to patients is 
minimized or circumvented” (Despins, Scott-Cawiezell & Rouder, 2010, p. 465). Nurses 
and nurse practitioners are at the forefront of patient assessment, which is the first 
opportunity for detection and intervention of potentially life-threatening illness and 
injuries. They have a responsibility to patients to be skilled in their assessment abilities 
and intervene when necessary. Charcot foot, although complex and often difficult to 
diagnose, is a major complication of diabetes that requires immediate treatment after a 
detailed and skilled assessment by competent healthcare professionals.  
The project design was a qualitative approach, which provided an opportunity for 
nurse practitioners to share their experiences and challenges when assessing the adult 
diabetic patient population. “Qualitative methods offer the opportunity to obtain an in-
depth understanding of patient experiences and may elicit a deeper understanding of 
patient’s perceptions and behaviors and the meanings they attach to their experiences” 
(LaVela & Gallan, 2014, p. 32).  
Background 
The American Diabetes Association reports that 60–70% of people with diabetes 
suffer from peripheral nerve damage, which can progress to Charcot foot and an 
estimated 0.5% of these patients will actually advance to Charcot. In the majority of 
cases, onset occurs following the age of 50 and after having been diagnosed with diabetes 
for 15 to 20 years (Peng & Swierzerswki, 2011). 
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Despite the fact that uncontrolled diabetes and loss of proprioception is the main 
contributing factor leading to Charcot, researchers now believe other predisposing 
elements may increase the risk such as widespread atherosclerosis, inflammation caused 
by minor injury, infection, ulceration, or any other disorder in which blood flow is 
impeded (Kaynak, Birsel, Guven & Ogut, 2013). Discovering the underlying etiology is a 
crucial aspect in successful treatment. The incidence and prevalence of Charcot is not 
known exactly but is estimated to affect 0.8-8% of the diabetic population. This number 
increases to 10% when radiographic studies are used in diabetics with neuropathy. In 
addition, studies have shown men and women are equally affected and typically in their 
5
th
 and 6
th
 decades of life and having had diabetes for at least 10 years or more (Gouveri 
& Papanas, 2011).  
Charcot is a devastating complication of diabetic peripheral neuropathy that may 
affect a person’s physical appearance and their ability to work and has the potential of 
having an effect on their mental capabilities as well. Patients are often left with feelings 
of depression, guilt from financial strains, and isolation. In addition, patients suffering 
from Charcot experience a high rate of depression and anxiety due to physical mobility 
restraints and chronic pain. Male patients are at an even greater threat of these 
complications as a resulting from an inability to work and provide for their families 
financially (Chapman, Shuttleworth & Huber, 2014).  
Finally, studies show that mortality rates of individuals with Charcot arthropathy 
are significantly higher than those who have simple diabetic foot ulcerations as well as 
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those with type 2 diabetes lacking foot complications at all. The comparable rates are 
28.3, 37.0, and 18.8% (Sohn, Lee, Stuck, Frykberg & Budiman-Mak, 2009).  
Significance for Future Practice, Research and Social Change 
The American Diabetes Association has developed recommendations for all 
healthcare practitioners to follow regarding the diagnosis, treatment, and surgical 
intervention of Charcot foot with the goal of rapid identification of signs and symptoms 
and appropriate treatment regimens as a means of preventing further complications. The 
guidelines address the areas of diagnostics, medical therapy, and surgical treatment of 
active Charcot neuropathy and stress the importance of early recognition and offloading 
and prevention of recurrence or new episodes of CN or other diabetic foot complications. 
(Rogers et al, 2011).  
Accurate assessment of the diabetic foot is a complex process requiring skill, 
experience, and knowledge of not only the disease but also signs and symptoms of 
potential complications. The loss of sensation due to peripheral nerve damage makes it 
difficult for providers to diagnose issues as well as unseen internal problematic issues 
such as destruction of bone tissue and cartilage as a result of uncontrolled hyperglycemia. 
It is critical that diabetic patients are adequately censored and made mindful of the 
possible complications that derive from this disease. Through lessening the percentage of 
amputations and enhancing quality of life by way of education and consistent monitoring, 
there will be a decrease in the amount of money spent on the long-term support of the 
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patient with diabetes (Meyers, 2013). However, many clinicians lack experience in the 
area of Charcot foot assessment and often consider it as simply “a diabetic foot”.  
According to Zgonis (2010), there is a limited amount of scientific literature in 
regard to treatment protocols and guidelines for management of Charcot foot and ankle 
deformities and may be in part due to the presence of each individual case of Charcot of 
the foot and ankle. Whereas many patients pose with obvious deformities, there are a 
higher number of those who have, little, or vague complaints, which add to the difficulty 
of accurate diagnosing for the practitioner.  
Due to the fact that type 2 diabetics are at risk for numerous multisystem 
complications, all healthcare personnel, including nurse practitioners, have a 
responsibility to patients to be knowledgeable and competent in advanced assessment 
skills in hopes of preventing further complications.  According to Rogers et al (2011), 
“the Charcot foot in diabetes poses many clinical challenges in its diagnosis and 
management. Despite the time that has passed since the first publication on pedal 
osteoarthropathy in 1883, we have much to learn about the pathophysiology, and little 
evidence exists on treatments of this disorder” (p. 2123). Identifying this problem in its 
initial stages is critical to effective treatment. Patients should contact a podiatrist at the 
earliest onset of symptoms. Occasionally, diagnosis is problematic given this condition is 
capable of mimicking other major disorders such as cellulitis or deep venous thrombosis, 
and especially since diagnosis of a Charcot fracture is unable to be made definitively until 
bone changes occur. The initial indications of the Charcot foot are frequently mild in 
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nature, but can become abundantly more pronounced with unperceived repetitive trauma. 
Charcot foot typically worsens slowly, with age; rapid progression is uncommon, and 
should motivate a rapid re-evaluation. Since undiagnosed Charcot can advance 
considerably to grim outcomes including infection, deformity, amputations, disability, 
loss of employment, financial and mental strains, and life-long devastating effects, it is 
crucial for practitioners to be knowledgeable and skilled in assessment and treatment 
methods. 
Implications for Practice 
Due to the rarity and often overlooked complication of peripheral neuropathy 
known as Charcot foot, diagnosis and treatment poses a critical issue for healthcare 
practitioners including nurse practitioners (Rogers et al, 2011). Therefore, an assessment 
and screening tool is needed to serve as a guide for nurse practitioners to assist in the 
early recognition and treatment and to prevent further injury and possible loss of limb.  
Nurses’ position in prevention of foot ulcers and amputations is imperative by means of 
education, screening high-risk populations, and assessment and intervention. Foot care 
education is vital for all diabetic patients but more so for those posing an increased threat 
due to neuropathy. Nurses can encourage and teach patients how to perform daily foot 
exams as well as consequences of untreated wounds or delay in care. According to the 
World Health Organization, diabetes is becoming an epidemic in most countries; 
therefore, evidence demonstrates significant consequences lie on both healthcare 
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providers as well as communities as a whole (Aalaa, Malazy, Sanjari, Peimani, & 
Moharjeri-Tehrani, 2012).  
Diabetic foot complications are key contributors to soaring morbidity and 
mortality rates. Without obvious signs of inflammation such as warmth, erythema, or 
function deficit, it is a demanding challenge for healthcare providers to diagnose Charcot 
foot. “Foot complications in people with diabetes can be difficult to treat and 
conventional therapies often fail, leading to amputations; thus, prevention of this 
condition is of paramount importance” (Houghton, Bower & Chant, 2013, p. 1). 
Advanced practice nurses must be willing to accept continuous new evidence and tools 
that will improve patient outcomes as an integral part of their practice. Patients rely on 
the knowledge and skill of healthcare professionals to ensure their well-being and 
positive outcomes. Assessment is a key element of the nursing role for all patient 
populations but more so for those individuals suffering from major diseases such as 
diabetes or other causes of peripheral neuropathy. According to the American Diabetes 
Association, 60–70% of people with diabetes acquire peripheral nerve impairment that 
can expand to Charcot foot and roughly 0.5% of these patients progress to Charcot. This 
data is especially relevant to nursing practice and advanced assessment skills. 
Implications for Social Change 
Diabetic neuropathy has the utmost widespread effect of type 2 diabetes with up 
to 50% of all diabetic patients affected. As per the American Diabetes Association 
[ADA] (2013), type 2 diabetes involves uncompromising systemic consequences, such as 
59 
 
 
 
peripheral neuropathy, which has the potential of leading to devastating injuries. Due to 
the loss of sensation, patients are often unaware of wounds or other abnormalities and 
therefore; delay seeking treatment. Additionally, due to the rarity of Charcot foot, 
healthcare providers often dismiss or overlook this serious complication and initiate other 
forms of treatment. According to Fowler (2007), “current statistics indicates diabetes will 
continue to affect the United States population for the foreseeable future and is by no 
means limited to the United States” (p. 42) The complications associated with this disease 
will also continue to be prevalent among those affected and it is the responsibility of 
providers to seek resources to assist them with accurate and appropriate diagnoses and 
treatment options. 
As with many other chronic health conditions, the social and mental aspects of 
type 2 diabetes can be devastating for patients, families, and care givers alike. Diabetic 
treatment regimens must be maintained on a daily basis, despite social pressures, 
economic status, or distracting life events (Welch, Jacobson & Weinger, 2008). While 
type 2 diabetes typically develops or manifests in middle adulthood, this may 
significantly influence motivation to seek treatment and may require greater efforts or 
willingness to change. Even in the early phase, subtle complications such as foot calluses 
may appear to be minor and unimportant for the diabetic patient, thus delay in seeking 
treatment. Other facets to consider are the costs of medical management of wound care, 
potential vascular interventions, infection control, wound closure, off-loading,  and 
alternative and adjunctive therapies.  
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Socioeconomic issues begin with extensive healing. For patients who are unaware 
of an injury, which progresses to an ulceration, “the average cost of treatment ranges 
from $3609 to $27, 721” (Sumpio, 2012, p. 13). Regardless of whether a patient is in 
need of complex therapy over an extended period of time or is simply required to be in 
some form of offloading device during the acute phase of Charcot foot, the potential for 
financial strain is inevitable. Complications of diabetic foot conditions are typically 
debilitating to patients, families, and caregivers alike. Patients are often times unable to 
continue working and have to rely on others or governmental assistance programs to 
sustain their daily lives. Others who are permanently disabled are forced to file for long-
term social security disability, which is an extremely long and drawn out process that 
may or may not be approved initially. For those who gain approval, the length of time for 
their first payment is typically six to seven months. Early detection is vital in 
advancement to further injury and reduces the incidence of long-term or permanent 
disability.  
Definition of Terms 
The principal terms used throughout this project included type 2 diabetes, 
peripheral neuropathy, Charcot foot, podiatric, acute, inflammatory, deformity, 
amputation, and offloading. 
Type 2 diabetes is the most common form of diabetes and is defined as a 
condition in which the body fails to utilize insulin properly, otherwise known as insulin 
resistance. Typically, the pancreas produces an excess of insulin to accommodate but, 
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over time it is adequately produce the body’s requirement of insulin to maintain blood 
glucose at normal levels (ada.org, n.d.).  Peripheral neuropathy refers to the destruction 
or dysfunction of peripheral nerves, which are damaged by uncontrolled elevated blood 
glucose levels, traumatic injuries, infections, metabolic problems and exposure to toxins 
(mayoclinic.org, n.d.). Charcot-Marie-Tooth (Charcot Foot or CMT) is named for three 
physicians who were first to describe it in 1886: Jean-Martin Charcot, Pierre Marie, and 
Howard Henry Tooth (CMTA, 2010). It is defined as a serious and potentially life-
threatening complication associated with diabetes, which is characterized by various 
degrees of bone, joint, soft tissue, foot and often ankle involvement and is derived from 
underlying neuropathy, trauma, and perturbations of bone metabolism and involves 
inflammation during the acute phase (Rogers et al, 2011). Podiatric refers to the specialty 
of a podiatrist who is a doctor of podiatric medicine (DPM), also known as a podiatric 
physician or surgeon. Podiatrists diagnose and treat conditions of the foot, ankle, and 
related structures of the leg (“what is a podiatrist?” 2014).  Acute is characterized by 
sharpness or severity, sudden onset, short course, or requiring short-term medical care (as 
for serious illness or traumatic injury) (merriam-webster.com, 2014). Inflammatory refers 
to having to do with the body's response to either invading foreign substances (such as 
viruses or bacteria) or to direct injury of body tissue (“inflammatory”, 2014). Deformity 
is defined as the quality or state of being deformed, disfigured, or misshapen 
(“deformity”, 2014). Amputation is the accidental or intentional removal of a limb or 
body part (“amputation”, 2014). Offloading refers to taking the load off or transfer from 
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one place to another such as reduction of pressure. Removing pressure from one area of 
the foot to another; effective reduction in pressure (“offload”, 2016). 
Evidence-Based Practice Model 
The problem identified within the adult type 2 diabetic population, who are at risk 
of Charcot foot, and the need for an assessment tool for healthcare practitioners is an 
example of the Iowa model of evidence-based practice. The Iowa model begins with a 
trigger or identified problem, which may also be a knowledge-based problem and 
involves the development of a team of stakeholders and a practice change is developed, 
implemented, and evaluated (Malone & Bucknall, 2013, 139). 
The Iowa Model for evidence-based practice includes knowledge and problem 
triggers, which prompt providers to evaluate current practices as well as promoting 
research when evidence is lacking (Rempher, 2006).  “The Iowa Model of Research in 
Practice infuses research into practice to improve the quality of care, and is an outgrowth 
of the Quality Assurance Model Using Research (QAMUR). Research utilization is seen 
as an organizational process. Planned change principles are used to integrate research and 
practice. The model integrates evidence-based healthcare acknowledges and uses a 
multidisciplinary team approach” (“Evidence-based Practice”, 2014). 
According to a study by Varaei, Salsali & Heshmat (2013), the Iowa Model was 
followed in a before and after design and included 19 baccalaureate nurses working on an 
endocrinology unit in which the primary patient population consisted of diabetics with 
chronic leg ulcers. The focus of the study was whether evidence based practice training 
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courses could improve nursing skills. Results indicated trained nurses can prevent 
significant complications in diabetic patients including amputations and other adverse 
effects by means of early recognition and treatment interventions.  
 This model has served as a reference for the project since the primary goal is 
directed at improving patient health and outcomes by identifying a trigger such as 
misdiagnosed Charcot foot, then integrating a multidisciplinary team to design an 
improvement plan such as assessment tool development and review of ADA policy and 
practice guidelines. “In this model, knowledge- and problem-focused triggers lead staff 
members to question current nursing practice and whether patient care can be improved 
through the use of research findings” (Titler & Moore, 2010, p. S3). Putting evidence into 
practice can be a complex process but necessary for improvements in healthcare and 
patient outcomes. The IOWA Model has been a valuable resource in the project by 
providing a systematic process to identify and address an issue in diabetic health. 
Theory 
Change is brought about in healthcare through various driving forces. The concept 
of identifying a problem and using evidence-based practice to implement change is an 
example of following the nursing process, which is a systematic approach to patient care 
with the goal of improving patient care. Lippitt’s theory of change is a model of nursing 
that mirrors the nursing process and follows the same four process elements including 
assessment, planning, implementation, and evaluation (Mitchell, 2013). The project has 
identified the problem of assessing the diabetic patient at risk of Charcot foot as a 
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problematic area for nurse practitioners due to its complexity and challenges in diagnosis. 
The plan was to develop an assessment and screening tool to aid in early detection in 
those patients at risk or who display clinical manifestations correlating to Charcot foot. 
The planning stage is designed to utilize the screening algorithm to determine the correct 
treatment or referral action for the patient and followed up at an appropriate time, which 
is the final evaluation stage.  
Literature Search Strategy 
The search for literature was conducted electronically and used the following 
databases: CINAHL, Medline, PubMed, EBSCO, and Walden University Library. 
Articles older than 10 years were not considered and the terms used for the search were: 
diabetes, type 2 diabetes, diabetes statistics, neuropathy, peripheral neuropathy, diabetic 
complications, Charcot, Charcot foot, Charcot-Marie-Tooth, podiatry, podiatric, 
orthopedic complications, foot deformities, diabetic assessment forms, foot assessment, 
offloading, and peripheral neuropathy assessment. 
Literature Review 
“Charcot neuroarthropathy is an often overlooked complication in diabetic 
patients with peripheral neuropathy. A group of experts reported that 25% of patients 
referred to their facility who had Charcot neuroarthropathy had not received a correct 
diagnosis at the referring institution. The incorrect diagnoses included infection, gout, 
arthritis, fracture, venous insufficiency, and tumor” (Botek, Anderson & Taylor, 2010, p. 
596). This article focused in detail on the devastating effects of misdiagnosed Charcot 
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and emphasized the importance of accurate assessment by healthcare providers. The 
authors also discussed a case in which a 53 year-old male presented to the emergency 
department with a 3 day history of pain, redness, and swelling to the foot and ankle and 
was misdiagnosed with cellulitis, admitted to the hospital for a course of antibiotics, 
discharged home with oral antibiotics, seen at his primary healthcare providers office 2-3 
more times for follow up, then finally referred to an orthopedic specialist where they 
were accurately diagnosed with Charcot foot in the acute phase. By this time, there was 
irreversible extensive damage to the foot. 
According to O’Rourke (2010), from 1999-2008 of patients who underwent either 
a below or above the knee amputation, 60% suffered from diabetic neuropathy and had 
some type of trauma, nonhealing wound or other complication such as Charcot foot. 
Based on an exhaustive review and analysis of the study, the primary issue for patients at 
a heightened chance of foot and ankle problems was the identification and referral to the 
appropriate specialist (O’Rourke, 2010). Healthcare professionals, including nurse 
practitioners, were among those who did not recognize potential issues, which delayed 
care and led to amputations of the 3,445 patients included in the study.  
Symptoms of Charcot foot affect sensory, motor, and autonomic systems of the 
body. When neuropathy progresses to Charcot arthropathy, it becomes a serious, potential 
limb-threatening complication and during the acute phase, is considered to be an 
inflammatory syndrome. Due to the rarity of this condition, diagnosis and treatment poses 
a critical issue for healthcare practitioners including nurse practitioners (Rogers et al, 
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2011). Therefore, an assessment and screening tool for nurse practitioners is needed to 
assist in the early recognition and treatment of Charcot foot to prevent further 
complications and possible loss of foot or lower extremity.  
Mumoli & Camaiti (2012) discussed a case of Charcot in the Canadian Journal of 
Medicine in which a 59 year-old male reported complaints of a plantar ulcer for two 
months but after examination, his healthcare provider discovered that his foot was also 
deformed; however, the patient had such severe neuropathy that he felt no pain at all. 
They go on to state early detection is essential and “prevention of disease progression 
remains the mainstay of treatment, including prompt immobilization, absolute non–
weight bearing and professional foot care on a regular basis” (p. 1392). While even the 
slightest of infection, injury, or minor surgery may trigger the body’s inflammatory 
response, without the protective barrier of pain being present, diabetic patients with 
sensory impairment are at greater risk of further injury and early recognition is crucial 
(Kaynak et al, 2013). 
Another valid argument derives from a literature review by Milne, Rogers, 
Kinnear, Martin, Lazzarini, Quinton & Boyle (2013), which discussed suggestions to 
assist healthcare providers in making early diagnoses of Charcot foot, choosing the 
appropriate treatment regimen and reducing the incidence of further complications 
including amputations, sepsis and death. “Charcot neuroarthropathy (CN) continues to be 
a persistent challenge for clinicians, especially in its acute phase. The report indicated 
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that the diagnosis of CN is missed in as many as 79% of cases and an accurate diagnosis 
can be delayed up to 29 weeks” (p. 9).  
According to Gouveri & Papanas (2013), accurate diagnosis of Charcot can often 
be challenging. The authors stress the significance of patient and physician awareness in 
order to gain prompt diagnosis and lessen the burden of foot complications. “Charcot 
arthroneuropathy is a potentially limb-threatening condition which, beyond the emotional 
and social burden of physical dysfunction, has been associated with increased mortality” 
(Gouveri & Papanas, 2013, p. 59). In addition, the article contains six practical point 
recommendations for clinicians to aid them in early detection and management and 
include: Charcot should be considered in every diabetic patient with neuropathy; 
irrespective of whether the diagnosis is only suspected, immediate offloading should be 
initiated; if plain x-rays are negative, this should not deter offoading; education to 
patients and physicians to increase early detection will be beneficial; ulceration or 
infection in the plantar aspect of the foot should be avoided and; surgical intervention 
may be required (consult a podiatric specialist). A detailed foot assessment and 
documentation utilizing a specified assessment tool, which follows ADA guidelines by a 
skilled practitioner, is recommended for all diabetic patients. 
Finally, according to Jackson (2011), many diabetic patients with existing 
neuropathy may present with other distracting issues such as foot ulcerations, swollen 
extremities, or have no complaints of pain or discomfort at all; clinicians still have the 
responsibility to perform a thorough examination of the diabetic foot and must be skilled 
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in their assessment techniques. Most complications of Charcot can be avoided with 
immediate treatment in the acute phase. While it is equally important to exclude other 
infectious processes or conditions such as DVT, “the overriding goal of treatment is to 
avoid amputation and prevent further deformity. Good outcomes can be managed with 
footwear that allows adequate gait and activity, thus sustaining overall quality of life” 
(Jackson, 2011, para. 2). 
Methods Approach: Introduction 
The purpose of this quality improvement project was to develop an assessment 
and screening tool and integrate ADA recommendations to assist healthcare providers in 
the early detection of Charcot foot for the diabetic population. The target population for 
this project was the adult diabetic population who have been diagnosed as having type 2 
diabetes for at least ten years, being treated with either oral hypoglycemic or insulin 
therapy, and those either having or at risk of peripheral neuropathy. Inclusion also 
involved those patients with a history of or currently being treated for any type of foot 
ulceration, wound, and injury, complaints of foot or ankle pain, and patients who have a 
documented change of foot appearance. Stakeholders for this project were the patients, 
private insurance carriers, Medicare and Medicaid, podiatrists, and healthcare 
practitioners who provide care to diabetic patients. This section will outline how the 
project achieved these development activities. 
The steps in the course of this project were as follows:  
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7. Assemble an interdisciplinary project team community of stakeholders to 
guide the project 
8. Review of best practices of diabetic foot assessment as presented in 
evidence-based literature. 
9. Integrate ADA policies and practice guidelines for the assessment, 
treatment, and referral of the diabetic patient with, or at risk for 
developing, Charcot foot in conjunction with the project team. 
10. Develop an assessment tool of the diabetic foot in conjunction with the 
project team 
11. Develop an implementation plan in collaboration with the project team 
12. Develop an evaluation plan in collaboration with the project team 
Interdisciplinary Project Team 
The multidisciplinary team members, consisting of five members, who were 
invited to participate in the project based on their knowledge and expertise in the area of 
diabetes and management of complications. Disciplines included diabetes education, 
nurse practitioner, podiatry, IT computer personnel, and nursing informatics. Members 
were selected for their knowledge and experience in treating diabetic patients, medical 
specialty in podiatric medicine, computer technology, and informatics. Each member 
reviewed ADA treatment recommendations regarding early detection and intervention of 
patients at risk of Charcot foot as well as appropriate treatment regimens. Utilization of 
valid resources such as medical specialists and those having experience in one particular 
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area is beneficial for ensuring all essential elements are included in the plan design. 
According to Nancarrow et al., (2013), interdisciplinary teamwork is “a dynamic process 
involving two or more health professionals with complementary backgrounds and skills, 
sharing common health goals and exercising concerted physical and mental effort in 
assessing, planning, or evaluating patient care” (p. 2) 
Team Literature Review 
The interdisciplinary team members each received a copy of the goals and 
objectives for the project prior to development of an assessment tool and were led 
through the review of scholarly literature.  Furthermore, a Gannt chart was dispersed to 
each member to illustrate the incidence of Charcot foot along with information from the 
American Diabetes Association and the American Podiatric Medical Association. All of 
the above was provided during an initial meeting with the interdisciplinary project team. 
Products 
Throughout the development of this project, I collaborated with a diverse group of 
experts who embodied the interdisciplinary team. The team members continuously 
provided input on the needs of the nurse practitioner stakeholders as well as feedback on 
the assessment and screening tool. The project was accepted and adopted by various NP 
clinicians in the geographical area who were willing to integrate it into their examination 
and treatment of adult type 2 diabetic patients. Furthermore, for those NPs who were 
utilizing electronic medical record systems, the project tools were incorporated as part of 
the patient assessment process for each visit.  
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Appendix A. 
Appendix A. is an example of the computation of a Scale Content Validation 
Instrument (S-CVI) for a 10-Item scale with two expert raters, which was used by two 
expert raters for ranking and validation of this project.  
Appendix B.  
Appendix B. is the Charcot Foot Assessment and Screening Tool to be used by 
nurse practitioners in the adult type 2 diabetic patient population who are at risk due to 
neurosensory deficits or other identified risk factors. The assessment and screening tool is 
based on the American Diabetes Associations’ (2011) recommendations, which could be 
utilized in the clinical setting and integrated into the patient’s electronic medical record. 
Focus points on the assessment were derived from key features of the foot, which 
included monofilament points, evidence of outward physical abnormalities, and severity 
of peripheral neuropathy. Patients who cannot reliably detect application of the 5.07, 10-g 
monofilament to designated sites on the plantar surface of their feet are considered to 
have lost protective sensation” (Morgan, 2013, para. 2). The assessment and screening 
tool also includes a recommendation for annual follow up or podiatric referral based on 
findings of the examination by way of a screening algorithm.  
Appendix C. 
Appendix C. is the Charcot Foot Screening Algorithm, which provides a clear 
guidance of treatment recommendations based on assessment findings. The algorithm is 
72 
 
 
 
designed to guide practitioners in the care and treatment of patients based on assessment 
findings. 
Appendix D. 
Appendix D. includes Charcot Foot Assessment and Treatment Practice 
Guidelines. Due to the potential life threatening complications of type 2 diabetes and the 
complexity in diagnosing Charcot foot, it is imperative that healthcare professionals, such 
as nurse practitioners, be educated and competent in their assessment skills. According to 
the U. S. Department of Health and Human Services Health Resources and Services 
Administration Bureau of Health Professions Division of Nursing; (2002), “the adult 
nurse practitioner employs evidence-based clinical practice guidelines to guide screening 
activities, identifies health promotion needs, and provides anticipatory guidance and 
counseling addressing environmental, lifestyle, and developmental issues” (p. 17). 
Providers must maintain a level of expertise to aid in the diagnosis and treatment of all 
major disease complications. 
Appendix E. 
Appendix E. includes the implementation and evaluation plan for the project. 
Implementation is an essential component in the success of the scholarly project and 
addresses the key objectives for the project and makes for a smoother transition for 
completion of the project (Moran, Conrad & Burson, 2014, p. 338). Equally important is 
the evaluation of the project by stakeholders to ensure the objectives are being met as 
well as opportunity for revisions. The intent of both the implementation and evaluation of 
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the project is to make certain that evidence-based practices are being followed (Forsyth, 
Wright, Scherb & Gaspar, 2010). 
Development of Products 
The proposed assessment and screening tool, treatment algorithm, and treatment 
and practice guidelines were developed by the project team for later implementation with 
the nurse practitioner community in Northern Texas where there are currently 65 
members of the Texas Panhandle Nurse Practitioners Association (TXPNPA). The 
assessment tool was distributed only to practitioners who are the primary care giver of 
adult type 2 diabetic patients. Part of the implementation phase included written forms of 
the assessment tool as well as the computerized version for those providers who have 
converted to electronic documentation. One benefit of utilizing the electronic medical 
record is the assessment tool will be a mandatory inclusion for providers, which will 
serve as an assessment reminder and hopefully reduce the number of undiagnosed cases. 
The computerized health information system being utilized at the health clinic has the 
capability of revisions to assessment templates and will be maintained by the clinic’s 
computer personnel. These plans were presented to the project team for consideration and 
refinement. The final DNP Project included an implementation plan developed by the 
project team. 
Validation of Products 
Content validation in the area of Charcot foot is essential in order to go forth with 
the development of treatment and practice guidelines. One method of validation is the 
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computation of a Scale Content Validation Instrument (S-CVI) for a 10-Item scale with 
two expert raters, which is defined as the proportion of items given a rating of quite/very 
relevant by both raters involved (Polit & Beck, 2006). This particular method allows the 
entire scale of items, up to 10, to be ranked by the raters as valid and relevant by the two 
experts and the proportion of total items judged content valid. An example of this scale is 
attached on Appendix A. 
Development of Implementation and Evaluation Plan 
The goal for this project is to pilot for a period of 6 months, which would allow 
area nurse practitioners ample time to integrate it into their diabetic patient exam and 
screening process. The project will include the assessment and screening tool, algorithm, 
and treatment and practice guidelines. At the end of the allocated time period, an 
electronic survey will be dispersed to practitioners via email to provide feedback on the 
project tools and forms.  
Project Dissemination 
Dissemination of the scholarly project is an important step in the DNP project. 
According to Ahmed, Andrist, Davis & Fuller (2012, p. 62), “it is our professional 
responsibility to share knowledge-knowledge generated from practice.” Among the 
various methods of disseminating the project, publishing in peer-reviewed journals ranks 
the most prestigious. This allows the scholar to project findings to professional 
colleagues rapidly. Another means is through poster presentations and at various 
conferences as a podium speaker. Regardless of the chosen method of dissemination, the 
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goal is to improve practice and patient safety through the process of developing a 
scholarly project.   
Dissemination of this project included a presentation at the annual nurse 
practitioner symposium two consecutive years and initially was presented as a project 
proposal. Throughout the following year, the assessment tool was developed with 
assistance from my DNP mentor and members of the project team. Final dissemination 
was conducted via podium presentation, as well as hand out copies of the assessment 
tool, with question and answer session following. By sharing the project with an area 
community network of nurse practitioners who are members of a particular region, I 
contributed to the growth and development of a community organization. This option is 
frequently overlooked but is an ideal collaboration to improve the overall health and 
well-being of those patients it serves (Anderson, Knestrick & Barraso, 2014). 
Discussion of Findings in Context of Literature 
The assessment and screening tool is an excellent guide to support practitioners in 
the evaluation of high risk patients such as diabetics suffering from peripheral 
neuropathy. In today’s world of healthcare, providers rely on multiple sources and 
experts to improve patient care through collaboration (Barry, 2015). Up until the mid-
1990s, Charcot foot was thought of as a rare sensory deficit condition but experts later 
recognized it as a destructive process, which led to immobilization to prevent further 
injury or trauma by making the patient non weight-bearing until the acute phase had been 
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resolved (Veillette, 2016, p. 99). Success of treatment is based on increasing awareness in 
practitioners who routinely provide care for the diabetic patient population. 
One study conducted by Botek, Anderson & Taylor (2010) described a 53 year-
old male who was misdiagnosed in the emergency department after presenting with 
multiple symptoms including pain, redness, and edema to the foot and ankle. This patient 
was admitted to the hospital and given a course of IV antibiotics, then discharged home 
with oral antibiotics and instructed to follow up with his primary care physician. After 
being seen by the PCP 2-3 additional times, the patient was eventually referred to an 
orthopedic specialist and diagnosed accurately with Charcot foot but the damage suffered 
to the foot and ankle was irreversible at that point.  
It is estimated that 0.1 to 5% of all diabetics will develop Charcot foot at some 
point during their disease with an increase in odds for those suffering from end-stage 
neuropathy. Furthermore, those patients with foot ulcerations are more likely to require 
extremity amputation; therefore, “it is extremely important for the foot and ankle 
specialist to judiciously approach the Charcot joint” (Bernstein, Ritter & Diamond, 2012, 
p. 2).  
As a result of impaired peripheral sensory neuropathy in patients suffering from 
type 2 diabetes, patients may have no specific recollection of injury. The earliest sign of 
Charcot foot may include a sudden change in the appearance of the foot or ankle and or 
discoloration (Sanders, 2014). Therefore, patients often delay seeking medical treatment 
due to vague symptoms or being unaware they have sustained any type of injury.  
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The current literature supports the need for further education and assessment tools 
to aid in the correct diagnosis and treatment referrals for patients who are at high risks for 
developing Charcot foot. It is imperative that practitioners be given every means of 
identifying these patients and intervening before life threatening complications occur. 
Currently, there are various advanced assessment tools available but are directed toward 
the advanced specialist skills.  
Project Strengths, Limitations, and Recommendations 
The strengths of the assessment and screening tool include the outlined specific 
areas of the foot to be assessed and inclusion of any identified abnormalities. Also, a 
section exists for pertinent patient data to be considered such as latest HgA1C levels, 
which indicate controlled or uncontrolled blood glucose levels over a three month period. 
This data is especially important since this directly relates to progression of healing. 
Additionally, the tool contains instruction for further treatment or referral based on the 
assessment findings.  
Limitations of the project involved an initial negate by one practitioner to accept 
the terminology of Charcot foot but rather felt it was simply a complication of diabetes 
and felt it could be treated as such. After further education and the development of the 
assessment tool, which was presented at the annual nurse practitioner symposium, the 
project and tool were more widely accepted. Furthermore, various other advanced 
practice nurses have since voiced an interest in gaining information on how to perform a 
more structured foot and ankle examination on their diabetic patient population. The 
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interest has been from practitioners within local acute care settings as well as community 
clinics. 
Recommendations for the project were made by members of the area nurse 
practitioners and consisted of the addition of BMI (body mass index) and specific 
interpretation of monofilament points to the assessment tool.  
Project Summary 
In summary, the DNP project has the potential to impact the diabetic patient 
population through a process of identifying a need and developing a project to address the 
issue through evidence-based practice. Charcot foot is a devastating and potential life 
threatening complication of diabetes and those suffering from peripheral neuropathy. As 
stated previously, many patients suffering from peripheral neuropathy or impaired 
sensory perception may experience injuries that are unaware until they begin to see 
visible signs of trauma such as edema, discoloration, or deformity. For these reasons, 
patients often times delay seeking treatment or are treated by healthcare providers with 
little or no knowledge on the clinical manifestations of diabetic foot complications.  
If left untreated, Charcot foot may progress to permanent disfigurement or 
amputations. Early detection and intervention is the key to preventing this serious 
condition. The development of an assessment and screening tool and following ADA 
recommendations will assist nurse practitioners and benefit the diabetic population. 
Currently, there are multiple assessment tools available to specialists in this area such as 
orthopedics and podiatry but are far more advanced than what is needed for early 
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recognition and referral for advanced practice nurses. After receiving feedback regarding 
a need from local advanced practice nurses, an assessment and screening tool was 
developed, along with screening algorithm and assessment and treatment practice 
guidelines, as a means to assist them in the care of the diabetic patient population who are 
at risk due to peripheral sensory deficits. In doing so, the goal is for immediate 
intervention, treatment, and referral to podiatry specialty if warranted and prevent further 
damage or injury.  
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Appendix A: Computation of an S-CVI for a 10-Item Scale with Two Expert Raters 
 
 Expert Rater No 1 Expert Rater No 2 Total 
Items rated 1 or 
2 
2 0 2 
Items rated 3 or 
4 
0 8 8 
Total 2 8 10 
S-CVI 8/10 = .80    
 
S-CVI, content validity index for the scale. 
Ratings of 1 = not relevant 
Ratings of 2 = somewhat relevant 
Ratings of 3 = quite relevant 
Ratings of 4 = highly relevant 
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Appendix B: Charcot Foot Assessment and Screening Tool 
 
Patient _________________________________   Management 
DOB________________Age________________    
Diabetes Type ________Duration_______   Insulin____________________ 
            
        Oral_______________________  
PCP______________________________________   Diet_______________________ 
        Latest HgA1C_____________ 
Height________Weight________BMI______     
     
     
 
Neuropathy Monofilament Testing Sites 
 
Monofilament testing for diabetic neuropathy using preferred testing 
locations colored green 
 
If all sites are tested and the client feels the monofilament in each of the areas; then 
the score is 10 /10  
   .  
If the monofilament is not felt in an area on the foot, this indicates loss of 
protective sensation (LOPS) in that area and requires referral to a podiatrist 
SKIN   
 
Turgor________________________________________Color__________________________________________ 
Temperature_________________________________Nails___________________________________________ 
Calluses_______________________________________Other__________________________________________ 
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SENSORY 
 
RIGHT FOOT      LEFT FOOT 
Sensation:  Present_______Absent__________  Sensation:  Present_____Absent_____ 
Numbness/Tingling         Yes____No_______  Numbness/Tingling Yes____No_____ 
Burning         Yes____No______  Burning                     Yes____No_____ 
Sharp Pain         Yes____No______  Sharp Pain               Yes____No_____ 
 
 
VASCULAR 
 
RIGHT FOOT      LEFT FOOT 
Pedal pulse:  Present_______Absent_________  Pedal Pulse: Present____Absent_____ 
Edema:  None____1+____2+____3+____4+____               Edema: None___1+___2+__3+__4+__ 
 
WOUNDS 
 
RIGHT FOOT      LEFT FOOT 
Ulcer Yes_____No_________    Ulcer Yes____No________ 
Description (approx. size in mm)   Description (approx. size in mm) 
_____________________________________________  _______________________________________ 
_____________________________________________  _______________________________________ 
 
DEFORMITIES 
 
RIGHT FOOT      LEFT FOOT 
Bunion  Yes_____No_________  Bunion     Yes_____No_______ 
Corns  Yes_____No_________  Corns      Yes_____No_______ 
Arch intact Yes_____No_________  Arch intact     Yes_____No_______ 
Other    _____________________  Other       ___________________ 
 
RISK LEVEL 
 
Low Risk_______      
No sensory loss, ulcerations, or deformities  
Treatment:  Annual Assessment    
 
Moderate Risk________ 
Altered sensory, minimal structural deformity, or beginning onset of ulcerations 
Treatment:  Refer to Podiatry 
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High Risk________ 
Impaired sensory, + numbness/tingling, healed or active ulcerations, amputation, 
deformities 
Treatment: Refer to Podiatry 
 
REFERRAL 
Name of Podiatrist_____________________________Date Contacted_____________________________ 
Person making referral________________________Appointment Date_________________________ 
Special instructions or treatment given by 
podiatrist_____________________________________________________________________________________ 
Signature of 
Provider_________________________________________Date________________________________________ 
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Appendix C: Charcot Foot Screening Algorithm 
Charcot Foot Screening Algorithm   
 
    No                Yes 
  
                
 
                
 
 
 
 
 
 
 
 
 
 
 
 
Numbness or 
tingling 
Decreased or absent 
pulses 
Deformities  
Active or healed 
ulcerations 
Amputations 
ANNUAL 
ASSESSMENT 
REFER TO 
PODIATRY 
History of erythema 
or swelling 
Lab values (ESR, CRP) WNL 
and 
No Abnormal radiographic findings 
Abnormal lab (Elevated ESR, CRP) 
and 
Abnormal radiographic findings 
NO YES 
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Appendix D: Charcot Foot Assessment and Treatment Practice Guidelines 
 
The following areas have been identified as primary focus points to aid in the detection, 
prevention, and treatment of Charcot foot in the diabetic patient population.   
 
HISTORY 
 Edema or erythema 
 Impaired neurovascular symptoms 
 Recent injury or trauma 
 Previous foot ulceration or amputation  
 
INSPECTION 
 Foot deformities or ulcerations 
 Erythema or blisters 
 Evidence of nonhealing areas 
 Dryness, cracking, calluses, or fungal infections 
 
MONOFILAMENT TESTING 
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 Recommended of four sites (1st, 3rd, and 5th metatarsal heads and plantar 
surface of distal hallux) be tested on each foot 
 Apply the monofilament along the perimeter of (not on) the ulcer site 
 Apply the monofilament to each site three times, including at least one 
additional  
mock application in which no filament is applied 
 
LABORATORY AND RADIOLOGIC TESTING 
 ESR and CRP (Erythrocyte Sedimentation Rate and C-Reactive Protein)  
 Radiologic exams on affected foot and ankle 
 
TREATMENT OR REFERRAL 
 Offloading of affected foot (orthopedic boot) 
 Non weightbearing of affected foot (crutches) 
 Referral to podiatry if identified as at risk or abnormal findings 
 Annual foot examinations of no abnormal findings or risk factors identified 
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Appendix E: Development of Assessment and Screening Tool 
 
Development of Assessment and Screening Tool  
to Assist with Prevention and Identification of Charcot Foot in Type 2 Diabetics 
 
IMPLEMENTATION PLAN and EVALUATION PLAN 
Goal: Promote patient safety, improve patient outcomes, and reduce the risk of infection, 
deformity, amputation, or loss of life. 
Objective Strategy/Tasks Stakeholder Date to be 
Completed  
Evaluation 
Status 
1.Assemble an 
interdisciplinary 
project team 
community of 
stakeholders to guide 
the project 
Collaboration of experts 
related to the treatment 
of adult type 2 diabetic 
patients, focusing on the 
diabetic foot 
Contact individual team 
members 
Adult type 2 
diabetic patient 
population 
October 1, 
2015 
Met 
2. Development of 
assessment and 
screening tool of the 
diabetic foot 
Collaborate with 
members of the 
interdisciplinary team for 
development of the tool 
Review various 
assessment tools 
currently being utilized 
by healthcare 
practitioners and 
incorporate key 
assessment areas as 
recommended by team 
experts as well as 
American Diabetes 
Association (ADA) 
recommendations 
Adult type 2 
diabetic patient 
population 
 
Advanced practice 
nurses 
February 1, 
2016 
Met 
3. Development of 
assessment and 
treatment algorithm  
Collaborate with 
members of the 
interdisciplinary team for 
development of the 
Adult type 2 
patient population 
 
March 1, 
2016 
Met 
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algorithm 
Follow ADA 
recommendations for 
treatment of Charcot foot 
Advanced practice 
nurses 
4. Development of 
treatment and practice 
guidelines 
Collaborate with 
members of the 
interdisciplinary team for 
development of 
guidelines 
Follow ADA 
recommendations for 
treatment of Charcot foot 
and collaborate with 
experts in the area of 
policy and practice 
guidelines 
Adult type 2 
patient population 
 
Advanced practice 
nurses  
April 1, 2016 Met 
5. Present assessment 
and screening tool, 
algorithm, and 
treatment and practice 
guidelines to area 
nurse practitioners 
Power point and oral 
presentation 
Present at annual nurse 
practitioner conference 
Advanced practice 
nurses 
April 23, 
2016 
Met 
6. Dissemination of 
project tools 
Electronic dissemination 
Email project tools 
Advanced practice 
nurses 
June 1, 2016 Not met 
7. Evaluation of 
project tools 
Electronic survey 
Email online survey link 
Advanced practice 
nurses 
December 1, 
2016 
Not met 
 
 
 
 
 
 
 
 
 
